FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1122,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,381460320.94968665,367778533.55245435,0.9641331309029206,-0.05269572225768804,0.9398509052172085,0.9586479233215527,Downregulated
Feature1121,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,5623479.9360757265,5470945.974229267,0.9728755212821292,-0.03967286985769991,0.8948692899729538,0.9279513339645602,Downregulated
Feature1120,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,1419775.0307866267,4005714.93683887,2.8213729992275627,1.4963974098309565,0.13466866843519879,0.30398802261806607,Upregulated
Feature1119,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,1939945.0784148024,2367004.983559043,1.2201402039140234,0.28704693456662045,0.6568394471296204,0.7574243162173012,Upregulated
Feature1118,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1175035.1991176321,4387293.07538004,3.7337545961811065,1.9006271084673971,0.17478047091636395,0.33188069332072495,Upregulated
Feature1117,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,881598040.494218,946893165.550658,1.0740645079245366,0.10308064366600529,0.8123200294838152,0.8696785048481305,Upregulated
Feature1116,NA,C30 H32 O10,552.19968,NA,NA,Feature1116,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Phenol,2516132.0979702133,4321442.158123113,1.7174941496947875,0.7803051847955195,0.06427488158936555,0.2524949108355725,Upregulated
Feature1115,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,256669315.255487,622735803.669626,2.426218354343443,1.278709395698538,0.0437515485194838,0.23105372564185667,Upregulated
Feature1114,NA,C9 H16 O7,236.0896,NA,NA,Feature1114,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,363415983.2368768,5912329.86677201,0.0162687667562445,-5.94175129722058,0.20399236780397054,0.3581837819656572,Downregulated
Feature1113,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,756203288.4034864,787073635.075241,1.0408228146388105,0.057724491116778444,0.586983836044471,0.7006338979169111,Upregulated
Feature1112,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1117665234.5214992,950345031.862616,0.8502948848270142,-0.23396483587345895,0.31630322222564733,0.46270171491157275,Downregulated
Feature1111,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,478260440.94052935,854059814.1745954,1.785763030065863,0.8365406481908453,0.026395378854565818,0.2042456212056748,Upregulated
Feature1110,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,57971319.46533397,44397674.96882993,0.7658558642153921,-0.38485519561990017,0.26329946612903415,0.4079465848703739,Downregulated
Feature1109,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,651366702.833723,818655905.6479363,1.256827992721203,0.3297872185505393,0.008820925136428449,0.16545908274686147,Upregulated
Feature1108,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,69989516.59390303,33648916.870118305,0.48077081408288436,-1.056578777157578,0.08769214161217385,0.28184191679182835,Downregulated
Feature1107,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,6573246.25980719,4577633.601928013,0.6964037890864425,-0.5220040422697603,0.044961890419405445,0.23105372564185667,Downregulated
Feature1106,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,712591226.904913,1100093389.2671494,1.543793057971431,0.6264793755025347,0.02934284621325586,0.20988072323333595,Upregulated
Feature1105,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,60173171.2393584,22535037.6398533,0.374503074637912,-1.416950531752977,0.08455580939398258,0.2798572806491105,Downregulated
Feature1104,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,980039953.186361,588014903.16427,0.5999907465532226,-0.7369878441740758,0.0031379357864296867,0.1302431386388236,Downregulated
Feature1103,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,12938215.599931587,12464680.787663477,0.9634002997854964,-0.0537927220326593,0.9068037112618568,0.9351413272387898,Downregulated
Feature1102,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,90458144.71914963,56743479.96278896,0.6272898934525305,-0.6727957759552322,0.01203252116212361,0.1733067798896166,Downregulated
Feature1101,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,880747483.1953499,1393433753.3177466,1.5821035880368026,0.661844063182643,0.03861036231555129,0.2294308083870162,Upregulated
Feature1100,NA,C32 H36 O10,580.23111,NA,NA,Feature1100,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,1397367.9474576784,2546142.39737786,1.822098755027422,0.8656011531725282,0.13189244457464522,0.30398802261806607,Upregulated
Feature1099,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,18974990.868771773,15861280.2749596,0.8359045010695323,-0.25858996562340575,0.8233413952839719,0.8746218664816003,Downregulated
Feature1098,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,843639846.0867227,988069327.4250797,1.17119803196625,0.2279850344902993,0.17460356988865322,0.33188069332072495,Upregulated
Feature1097,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,127938606.01852678,826126.3710972139,0.006457209413221077,-7.2748734688953185,0.23501250448610855,0.3819254480242743,Downregulated
Feature1096,NA,C6 H11 N O7,209.05352,NA,NA,Feature1096,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,235405092.358823,485488195.5405587,2.062352138077537,1.0442906879358356,0.0013400729249543107,0.1302431386388236,Upregulated
Feature1095,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,432436992.58979267,116013807.215701,0.2682791000855726,-1.8981934270848726,0.02240730877113806,0.202913517900705,Downregulated
Feature1094,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,6958915.329896926,7196873.796019264,1.0341947638161395,0.048507905509638266,0.9034020112177383,0.9324903924437005,Upregulated
Feature1093,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,139756922.975066,178772198.674445,1.2791652454049787,0.3552026468053131,0.0776463009363656,0.26971872956842785,Upregulated
Feature1092,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,26276613.087375835,18422453.085667234,0.7010969421518787,-0.5123141523745806,0.1809849728696403,0.337317507574313,Downregulated
Feature1091,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,728320.615332342,1343498.4267679632,1.8446524765125696,0.8833490452088111,0.059684716458310964,0.2524949108355725,Upregulated
Feature1090,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,2893434.3741580863,2443993.63092873,0.8446687620623393,-0.2435423973002128,0.6800894731769411,0.7731901288651981,Downregulated
Feature1089,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3140093.7751261103,2248121.3571871333,0.7159408343137287,-0.4820877274663943,0.4814790504829754,0.6152841624622989,Downregulated
Feature1088,NA,C16 H29 N O12,427.16894,NA,NA,Feature1088,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,5962213.38245727,3733162.057929863,0.6261369425176923,-0.6754498711404789,0.18577163263928678,0.3445219368946773,Downregulated
Feature1087,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,5857747.209973247,6925039.404183533,1.1822018185409473,0.24147634495198161,0.16685023699378043,0.3255755928817768,Upregulated
Feature1086,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,141905378.9538151,709662950.7078463,5.000958779292046,2.3222047135925696,0.0251670912994244,0.202913517900705,Upregulated
Feature1085,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,307302823.17543435,326194388.04338765,1.061475402903046,0.0860709407007145,0.5416146253811452,0.6634187878576909,Upregulated
Feature1084,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,1003119.7129663967,4081206.569121433,4.068513973324885,2.024501945647699,0.07184628540277072,0.26343637981015927,Upregulated
Feature1083,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,259540309.60929933,263395057.64931333,1.0148522133067375,0.021269651890215874,0.950928299620116,0.9681865264734758,Upregulated
Feature1082,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,37701615.385787435,29224327.257237967,0.7751478804872326,-0.36745652502504295,0.5084185456406891,0.6352400982281216,Downregulated
Feature1081,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,2709733.793858956,1046954.0092783757,0.3863678460412154,-1.371953058392442,0.26204371851641106,0.407381507964386,Downregulated
Feature1080,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,89174746.42393766,461001839.9319947,5.1696456499061645,2.3700653953093953,0.0030207673826772633,0.1302431386388236,Upregulated
Feature1079,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Phenol,280027721.6533033,297249902.35276467,1.0615016991809967,0.08610668061496794,0.5299822953935839,0.6545147611265029,Upregulated
Feature1078,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,69440066.0982279,59406954.7405912,0.855514086875376,-0.2251364845935666,0.6674812100710439,0.7657606520446946,Downregulated
Feature1077,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,1379230.026514269,813375.5745531704,0.5897316320822975,-0.7618695152360255,0.5820498496404372,0.6962259395485827,Downregulated
Feature1076,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,820634.0216315957,916747.379465604,1.117120854486284,0.15978527063450115,0.5656954698968014,0.6846928988394944,Upregulated
Feature1075,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,353133226.159715,120876565.33527833,0.3422973438376153,-1.5466779975357206,0.09041517848095715,0.2828485191409447,Downregulated
Feature1074,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3094796.8362434767,6223744.73216122,2.0110349924345017,1.007938185060724,0.039825717955736646,0.2294308083870162,Upregulated
Feature1073,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,243373482.58666167,259174972.7627507,1.0649269181183794,0.0907544271779614,0.3759462762008261,0.5150326274692636,Upregulated
Feature1072,NA,C9 H17 N O6,235.10555,NA,NA,Feature1072,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,348099632.9854613,122528203.315588,0.3519917624294235,-1.506386428642066,0.08870199991183261,0.28184191679182835,Downregulated
Feature1071,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1071,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,159783.31103547732,295578.901542726,1.8498734293789758,0.8874265631447842,0.11391038232551823,0.29530270911052897,Upregulated
Feature1070,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,163089668.549052,323972087.6159153,1.9864660373534033,0.9902041278530564,0.013676562032628778,0.17843142558848243,Upregulated
Feature1069,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8907881.799718827,53916987.321860336,6.0527281944358755,2.5975855664216567,0.03703414538589376,0.22796760781090802,Upregulated
Feature1068,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,84196.88395271944,882874.0159702373,10.48582767583196,3.3903688367883245,0.10307994880617255,0.29205985495082226,Upregulated
Feature1067,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,362091.92751918634,803286.3104622466,2.218459593854609,1.1495582767207044,0.24876978931319918,0.39710778173245215,Upregulated
Feature1066,NA,C29 H30 O10,538.18407,NA,NA,Feature1066,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,617993.8381513903,1132154.3166470719,1.831983179692687,0.873406257427571,0.11158985225925401,0.29530270911052897,Upregulated
Feature1065,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,68931326.74707873,52268283.37574183,0.7582660285580087,-0.399224005398623,0.4760460739290075,0.6104270799409673,Downregulated
Feature1064,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,23066107.7241352,23811288.045087602,1.0323062880770595,0.04587108580945419,0.939642045209397,0.9586479233215527,Upregulated
Feature1063,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,155328205.19747433,301930606.89217335,1.943823444739596,0.9588971865537598,0.012933709423598163,0.17483881895514625,Upregulated
Feature1062,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,51263220.708418965,42028240.641633764,0.8198517389433446,-0.2865650569009541,0.10610828625943311,0.2923176437002599,Downregulated
Feature1061,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,4328889.699525436,1075724.9890150768,0.24849905257068697,-2.0086877435190247,0.2020516435256959,0.35539505387094084,Downregulated
Feature1060,NA,C9 H19 N O7,253.11617,NA,NA,Feature1060,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,53888767.933246806,279729.2514807269,0.005190863740422376,-7.589809667014604,0.1989223999634169,0.35539505387094084,Downregulated
Feature1059,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,82792232.73025207,31513202.2038158,0.3806299354975718,-1.3935390648162886,0.3090542627872351,0.4538728833079552,Downregulated
Feature1058,NA,C6 H14 O4,150.08923,NA,NA,Feature1058,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,307938170.2185107,338728894.466153,1.0999899565091054,0.13749035124024764,0.5393699916300699,0.6613913995726104,Upregulated
Feature1057,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1057,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,175590.7577705,328026.19048511266,1.8681290214251953,0.9015940975220742,0.13631472084589816,0.30398802261806607,Upregulated
Feature1056,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1056,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,38095682.3000742,34086439.411311135,0.8947586013243487,-0.16042958753562916,0.453701566958181,0.5926113598685436,Downregulated
Feature1055,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Phenol,178958060.261837,268761982.83870065,1.5018154669617552,0.5867075550263169,0.012511452024116706,0.1733067798896166,Upregulated
Feature1054,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,1483321.0505763076,1334771.0037101568,0.8998530717214352,-0.15223863789326414,0.8022318641766031,0.863823562002062,Downregulated
Feature1053,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,55901983.86684847,81946145.65196927,1.4658897588886064,0.5517766107807548,0.025283273775546924,0.202913517900705,Upregulated
Feature1052,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1546943.6871439593,849754.0491789773,0.5493115594581426,-0.8643034433050008,0.25212601264094275,0.399555630202172,Downregulated
Feature1051,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,7073970.065893884,3519664.92163927,0.49755157130347805,-1.0070820258988662,0.206997642908618,0.3617622357374913,Downregulated
Feature1050,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Phenol,493421.142350191,875606.4481949974,1.774562079007068,0.8274630446772893,0.025654427154452326,0.2036120750043096,Upregulated
Feature1049,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,24985989.245242734,26955078.154739734,1.0788077226068569,0.10943775420444991,0.635982294539214,0.7433043067427063,Upregulated
Feature1048,NA,C6 H15 N O7,213.0849,NA,NA,Feature1048,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,6811622.304104997,5284047.9312566435,0.7757400066166665,-0.3663548883701605,0.5294060644774828,0.6545147611265029,Downregulated
Feature1047,NA,C10 H20 O7,252.12091,NA,NA,Feature1047,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,1996714.462050357,1402379.453654115,0.7023435149631061,-0.509751272165875,0.6258702040816324,0.7337788599577759,Downregulated
Feature1046,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,162647464.235339,187408577.58553132,1.1522379304626897,0.20443865571724296,0.476926962236186,0.6108585064257999,Upregulated
Feature1045,NA,C12 H18 O9,306.09515,NA,NA,Feature1045,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4180694.20336399,948064.01778447,0.2267719119522331,-2.140686136250442,0.06265460840139933,0.2524949108355725,Downregulated
Feature1044,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,359651.0243001353,665665.8807942253,1.8508660779976396,0.8882005107684858,0.32008968288861134,0.46679726866154747,Upregulated
Feature1043,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,257014807.125892,396041129.67467135,1.5409272878222962,0.6237987865943238,0.12682102125067557,0.30136820559300176,Upregulated
Feature1042,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,575398.1765689506,1048432.3012308113,1.8220987551307897,0.8656011532543723,0.13189244456992882,0.30398802261806607,Upregulated
Feature1041,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,7301116.903780793,17464384.1985373,2.3920154174621677,1.2582266882920927,0.056481591325018995,0.2456021082352369,Upregulated
Feature1040,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,39938125.75096373,1262855.43170127,0.031620297847121594,-4.983005232561,0.2172409735398933,0.37043217676559315,Downregulated
Feature1039,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Phenol,610906.8182584806,1071668.9630320175,1.7542265546929676,0.8108350808642719,0.060946532899234816,0.2524949108355725,Upregulated
Feature1038,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1269250.67880766,1333703.5811312967,1.0507802780016506,0.07146102802781812,0.648429696905448,0.7515889668676785,Upregulated
Feature1037,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,322061.58169343235,590744.5539756643,1.8342596185160296,0.8751978504038969,0.1236147670953187,0.30136820559300176,Upregulated
Feature1036,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,14256018.034291632,11336649.349834133,0.7952185050948163,-0.33057676542945175,0.08766730110306944,0.28184191679182835,Downregulated
Feature1035,NA,C9 H17 N O6,235.10557,NA,NA,Feature1035,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,79084460.141933,87778903.74794483,1.1099387109731533,0.15048001547962397,0.795870754919084,0.8595908313223575,Upregulated
Feature1034,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,111725.0230608379,181405.570494967,1.623678971148529,0.6992664154572262,0.13084793184352697,0.30398802261806607,Upregulated
Feature1033,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1033,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,11810585.03366318,12442454.678161632,1.053500283237237,0.07519070202888065,0.8138724754317304,0.8698791207794081,Upregulated
Feature1032,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,5785880.34477042,2507514.9884407865,0.4333852134891122,-1.2062781633981903,0.25384858034939045,0.4005880550661267,Downregulated
Feature1031,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,8674945.55253313,51734107.06198197,5.963623258347177,2.5761891207196217,0.04259027133914968,0.2294308083870162,Upregulated
Feature1030,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,206395835.149803,239630943.262212,1.161026059892569,0.21540035468051222,0.10499451807702985,0.29231724387699126,Upregulated
Feature1029,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,538708.451115591,705602.7247931713,1.3098044467874326,0.38935143412194717,0.41674899062893256,0.5527292974474787,Upregulated
Feature1028,NA,C22 H33 N O6,407.23081,NA,NA,Feature1028,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,632766.3460062731,1041029.3351539379,1.6452033862490176,0.7182659463890784,0.15516569140250275,0.31653801046110563,Upregulated
Feature1027,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,241040.90774990467,471543.5014800793,1.9562799770457877,0.9681128593443964,0.08849487178777421,0.28184191679182835,Upregulated
Feature1026,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,12445950.6629486,2477320.1039880365,0.19904627385057694,-2.328824230479504,0.006492170760885711,0.1493750767119406,Downregulated
Feature1025,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,13432289.404316343,7524775.77489963,0.5602005397889664,-0.8359847213455431,0.09017865287765457,0.2828485191409447,Downregulated
Feature1024,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,183384852.38509235,264075398.33952934,1.440006603080792,0.526075427091249,0.02433776447061516,0.202913517900705,Upregulated
Feature1023,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,26097756.4342352,6578253.551084343,0.2520620332886144,-1.9881492655096695,0.14584571045251127,0.31110054587018565,Downregulated
Feature1022,NA,C10 H15 N O8,277.07983,NA,NA,Feature1022,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,45983422.78136027,31321069.153080467,0.6811382724162217,-0.5539803969732362,0.27061586039125923,0.4143998630671455,Downregulated
Feature1021,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1021,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,153315638.098722,176868900.03451267,1.1536259590207256,0.2061755337422584,0.2227742051946277,0.3749957127248786,Upregulated
Feature1020,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,7462099.14753481,15657078.0434636,2.0982136170940713,1.0691615647758859,0.12020555027462226,0.29895458820322796,Upregulated
Feature1019,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1019,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,660624.0470667733,1056665.6930327134,1.5994962607316499,0.6776176197557368,0.11243232593036603,0.29530270911052897,Upregulated
Feature1018,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,9278428.30361528,790703.7895366143,0.08521958284988004,-3.5526712002379672,0.06626255451274878,0.2532914099903398,Downregulated
Feature1017,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,58918386.6886832,75667195.24512321,1.2842713369756449,0.36095004292235366,0.20432372515780614,0.3582050306672789,Upregulated
Feature1016,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,28854259.753161833,23179223.870236266,0.8033206905505972,-0.3159520594403821,0.1945977009566195,0.3514415367485534,Downregulated
Feature1015,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,317612.33609786164,615165.9405897583,1.9368452376491305,0.9537086809436476,0.08855871957394097,0.28184191679182835,Upregulated
Feature1014,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,129550385.2790322,49798937.3988214,0.3843982192068508,-1.3793264423017035,0.03874063695251582,0.2294308083870162,Downregulated
Feature1013,NA,C10 H17 N O9,295.09039,NA,NA,Feature1013,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,53635101.8124524,36176418.8616753,0.6744914736654096,-0.5681278888945145,0.064299246320121,0.2524949108355725,Downregulated
Feature1012,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,41301714.10165947,36161742.8980074,0.8755506565417451,-0.19173744412415392,0.6726417760269534,0.7677718701445977,Downregulated
Feature1011,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,12466804.824313743,21796991.762812633,1.7484024230733464,0.8060372826376596,0.3430006719584097,0.48714778979409584,Upregulated
Feature1010,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,70795182.12669523,160404984.86053166,2.265761313721469,1.1799958886749526,0.0741579430751196,0.26632745741913066,Upregulated
Feature1009,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,158938650.248421,156989412.503332,0.9877359110446555,-0.01780273197950176,0.8627318066998886,0.9055052264894996,Downregulated
Feature1008,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,21039988.167529367,16043770.4543134,0.7625370473864362,-0.3911206631837579,0.06560847079780231,0.2530448383281144,Downregulated
Feature1007,NA,C7 H15 N O5,193.09509,NA,NA,Feature1007,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,49457536.88322437,18853693.39633563,0.3812097120981103,-1.391343219560568,0.07339437903044038,0.26478615200049554,Downregulated
Feature1006,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,22340492.577219065,23545248.0730635,1.0539269889274037,0.07577492735391665,0.7589172602889085,0.8331753092408566,Upregulated
Feature1005,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,12766958.602546323,3671630.557419543,0.2875885065286614,-1.7979220752486758,0.021439484072142995,0.20138456856034048,Downregulated
Feature1004,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,62158683.005098894,18748587.36814394,0.30162459147672077,-1.7291740384452023,0.11970327671270073,0.2984601699370005,Downregulated
Feature1003,NA,C6 H14 O4,150.08924,NA,NA,Feature1003,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,165880692.44635135,72935102.40019369,0.43968409659118196,-1.185460743787721,0.03510027000044409,0.22518500080187337,Downregulated
Feature1002,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,1430342.437145562,2812904.54886737,1.966595184353821,0.9757000152520628,0.2277091112450165,0.3780008505232887,Upregulated
Feature1001,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,225619.32448482135,357907.7371600893,1.58633458360597,0.6656970908405532,0.10466699908894471,0.29231724387699126,Upregulated
Feature1000,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,45879230.394297704,21846765.822976433,0.47617986690752667,-1.07042147076525,0.23499667273760375,0.3819254480242743,Downregulated
Feature0999,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,3928017.7613749234,6576085.651254343,1.6741486548045843,0.7434276366263268,0.1842325868228907,0.34223338148225724,Upregulated
Feature0998,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,23319256.566259168,13766345.278156154,0.5903423738677328,-0.7603761949538428,0.08451239773923254,0.2798572806491105,Downregulated
Feature0997,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,42566295.606997564,39132961.8935526,0.9193414962592951,-0.12132723397747049,0.7952807533183935,0.8595908313223575,Downregulated
Feature0996,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,85091807.6904823,97100737.35326557,1.1411290932549607,0.1904620095615424,0.2158862218040823,0.37037360988406776,Upregulated
Feature0995,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,100094845.5449857,149338189.679802,1.4919668327245166,0.5772154640142465,0.04368490432874002,0.23105372564185667,Upregulated
Feature0994,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,7822195.08283682,5987966.174348857,0.7655096952884028,-0.38550744511014695,0.3512139103739053,0.4946130096374076,Downregulated
Feature0993,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,5218164.494113463,4250998.770424654,0.8146540369166485,-0.295740581790732,0.19058021718507892,0.3475836870484041,Downregulated
Feature0992,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1098741.6929248758,1247740.9553226484,1.1356090001473715,0.18346618814511356,0.7917552607803883,0.8595908313223575,Upregulated
Feature0991,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,65577507.2901124,73641512.96549967,1.1229690790122964,0.16731820363363745,0.8719979309041368,0.9109699054696848,Upregulated
Feature0990,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,35619428.4426376,55552479.785374165,1.5596117684717272,0.6411869461342485,0.080146331165536,0.274433338112963,Upregulated
Feature0989,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,56623128.693428405,104284097.1547849,1.8417226239723479,0.8810557980458943,0.08224265648871469,0.27545152412041163,Upregulated
Feature0988,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,689108.3984053027,2369430.1293851733,3.4383997276312117,1.7817372735969486,0.02088973862177366,0.20032723703957303,Upregulated
Feature0987,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,5860682.968333676,6140376.650863687,1.0477237352781656,0.06725835591483925,0.8474926251159974,0.8920013969838719,Upregulated
Feature0986,NA,C18 H31 N O11,437.18971,NA,NA,Feature0986,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,9865182.81111112,2367385.106589297,0.23997376956085592,-2.059051374856048,0.004631801944246586,0.1411594118186735,Downregulated
Feature0985,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,56115267.68724293,43749895.97412393,0.7796433622657367,-0.3591137621340231,0.0034957281435314836,0.1302431386388236,Downregulated
Feature0984,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,290491.1092005273,419445.106530398,1.4439171914237594,0.5299880061115465,0.30793235135959707,0.4528179531133262,Upregulated
Feature0983,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,9605813.224214258,7107900.271239337,0.7399582008654716,-0.43448431753400485,0.051210109928828657,0.23940726391727396,Downregulated
Feature0982,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,110711949.39363533,123503411.472728,1.1155382246374574,0.15773994930601024,0.17206846780229304,0.33139764286350143,Upregulated
Feature0981,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,31233925.53620833,40941486.75349733,1.310801830081697,0.39044959221969555,0.24080679727677234,0.38851390663673335,Upregulated
Feature0980,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,16325294.0809205,25614608.68403097,1.5690136151340124,0.6498578713634334,0.09444489930171233,0.289527806056069,Upregulated
Feature0979,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1036789.503841758,4729306.763642357,4.561491745545465,2.189505706397902,0.0034693745309937554,0.1302431386388236,Upregulated
Feature0978,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,30153958.9137516,20614744.197957203,0.6836496745558649,-0.5486708666390887,0.3849570743693422,0.5235416211423054,Downregulated
Feature0977,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,5424589.8226044495,2796897.0589713263,0.5155960451270549,-0.9556868973194272,0.08022650169434212,0.274433338112963,Downregulated
Feature0976,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,12215103.882184267,7782757.468695947,0.6371421433465745,-0.6503128281758219,0.05540014081705839,0.24513653722181605,Downregulated
Feature0975,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1417238.70691793,1111262.1952331902,0.784103757404321,-0.35088352168429576,0.030125704837725628,0.20988072323333595,Downregulated
Feature0974,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,39050477.95431773,21256799.661672167,0.5443416002881943,-0.8774157993422801,0.06218707215728216,0.2524949108355725,Downregulated
Feature0973,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,103888310.2845349,151299204.85018066,1.4563640936674611,0.5423710770084499,0.04121212576557492,0.2294308083870162,Upregulated
Feature0972,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature0972,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,863840.0456787583,603862.0621434143,0.6990438393822463,-0.5165451602078098,0.01860216392655008,0.1914215549792269,Downregulated
Feature0971,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,15890127.12292874,1916869.9033235833,0.12063276073843525,-3.05130633577135,0.22607480103535613,0.3776098707557998,Downregulated
Feature0970,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2606095.80467475,5345724.279287437,2.0512385882738498,1.0364953075664,0.06078942654688192,0.2524949108355725,Upregulated
Feature0969,NA,C43 H79 N O9,753.57577,NA,NA,Feature0969,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,35539041.43560482,34426955.83738121,0.9687080587066856,-0.045866151348087913,0.9807695859471742,0.9877263249984356,Downregulated
Feature0968,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature0968,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,142699.49724191232,252473.844517475,1.769269334491536,0.8231536850877902,0.0697720022750051,0.25816279289075317,Upregulated
Feature0967,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature0967,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,185168.66473197268,253838.35246547635,1.3708493974015605,0.455070084205102,0.12731597990292587,0.30136820559300176,Upregulated
Feature0966,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,62419544.90779947,84401639.6373838,1.352166853540094,0.43527318706553486,0.15425534221694265,0.31604977772306975,Upregulated
Feature0965,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,67113430.15247643,91866762.7457652,1.3688283036204698,0.4529414962306753,0.002369886835276132,0.1302431386388236,Upregulated
Feature0964,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,627397.239165007,1087553.3945967527,1.7334366916312227,0.7936351475661179,0.12324412349806559,0.30136820559300176,Upregulated
Feature0963,NA,C12 H18 N6,246.15928,NA,NA,Feature0963,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,33963960.54111997,53595920.95859927,1.5780232960084557,0.6581185036959779,0.7701587436957649,0.8405818194811752,Upregulated
Feature0962,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,3180281.27090867,12984231.993899623,4.082730704567451,2.0295344110610265,0.29657735160474236,0.44074144172254426,Upregulated
Feature0961,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,101347754.4887007,61588112.143143706,0.6076909395166736,-0.7185903129793916,0.007992438359817527,0.1595031612923729,Downregulated
Feature0960,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,85853593.82450937,111369997.10093433,1.2972083303650892,0.3754101935824393,0.0031819532325106327,0.1302431386388236,Upregulated
Feature0959,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,287178.29392893,560631.3273803527,1.9522064836804691,0.9651056539393766,0.07643265712028528,0.26632745741913066,Upregulated
Feature0958,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,92550578.20807888,7052508.6914223125,0.07620167078336727,-3.7140335594517593,0.012808178652880694,0.17483881895514625,Downregulated
Feature0957,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Phenol,22238106.219805416,152447308.031769,6.855228881675111,2.7772048353619225,0.006162095077224077,0.1493750767119406,Upregulated
Feature0956,NA,C9 H15 N O7,249.08484,NA,NA,Feature0956,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,53455161.4903797,44559639.3511471,0.8335890886638978,-0.26259170142822286,0.336030551184597,0.4833186502690492,Downregulated
Feature0955,NA,C23 H35 N O6,421.24649,NA,NA,Feature0955,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,2573940.3878546366,5074391.544356003,1.9714487438403643,0.9792562019655895,0.16300581039561418,0.32086406888399843,Upregulated
Feature0954,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature0954,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,36788985.0480717,5710607.57166773,0.15522601572741818,-2.687557722829276,0.04476943156764684,0.23105372564185667,Downregulated
Feature0953,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,79257037.65683393,75608624.29636313,0.9539673262042968,-0.06798824074281537,0.4828316764235714,0.6158162301349744,Downregulated
Feature0952,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,11678227.963399107,7908889.405845086,0.6772336891035561,-0.5622743527617114,0.2079926804542764,0.3618105232088343,Downregulated
Feature0951,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1502991.1017723246,26140064.935069967,17.392029070728128,4.120354351827978,7.281499706663365e-4,0.1302431386388236,Upregulated
Feature0950,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,44443690.59052697,8424677.414693024,0.1895584570667657,-2.3992852717414594,0.1401640463383823,0.3094889519155126,Downregulated
Feature0949,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature0949,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,3525014.9014267568,3173165.5207566065,0.9001849948130038,-0.15170657825242329,0.3364276879323774,0.4833186502690492,Downregulated
Feature0948,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,12146036.9632766,10275195.797034036,0.8459710626685041,-0.24131977960200773,0.1364680100206333,0.30398802261806607,Downregulated
Feature0947,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,55942293.3742723,65148739.483871564,1.1645704091536813,0.2197978665698952,0.10414258184567901,0.29231724387699126,Upregulated
Feature0946,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,34329693.02327937,22336583.8129999,0.6506490983724555,-0.620048401764692,0.45177221768480624,0.5907790538955159,Downregulated
Feature0945,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature0945,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Phenol,386540.24978773866,150816.21487127032,0.39016949710693316,-1.3578271003660844,0.048880117415169705,0.23924543223939654,Downregulated
Feature0944,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1487224.0856103434,1425959.7828184334,0.958806273120054,-0.06068874684150688,0.8789232497402826,0.9156470624035256,Downregulated
Feature0943,NA,C15 H18 O11,374.08496,NA,NA,Feature0943,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,116192.25048866487,186684.24839094665,1.6066841601381896,0.6840863537883671,0.11775503280721784,0.2969014535049403,Upregulated
Feature0942,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,19080492.286561865,12415596.759265149,0.6506958296882773,-0.6199447873636742,0.0439141980912381,0.23105372564185667,Downregulated
Feature0941,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,17213242.357991133,1916206.1977315608,0.11132163004966783,-3.1671941559942205,0.2332136687816636,0.3819254480242743,Downregulated
Feature0940,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,71923176.0162513,89074722.37048903,1.2384703694169774,0.3085593523093014,0.0171726038123851,0.1914215549792269,Upregulated
Feature0939,NA,C10 H21 N O9,299.12162,NA,NA,Feature0939,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,21533055.23863473,12590385.1389799,0.5847003594914928,-0.7742306165575172,0.09003645707692609,0.2828485191409447,Downregulated
Feature0938,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature0938,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,1140123.2071133696,5522042.126489096,4.843373147775954,2.2760121567094656,0.03697876197397469,0.22796760781090802,Upregulated
Feature0937,NA,C16 H27 N O14,457.14329,NA,NA,Feature0937,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,76090230.64353333,27602774.448673535,0.3627637111258961,-1.4628979510308855,0.00971891678131274,0.16790950029356227,Downregulated
Feature0936,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,47445844.93507697,70301728.5852354,1.4817257165813682,0.567278413938992,0.049784978987081195,0.23924543223939654,Upregulated
Feature0935,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4916287.628218616,18668396.905846234,3.797254822661912,1.9249568172490845,0.004654989516302068,0.1411594118186735,Upregulated
Feature0934,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,36058411.201271564,39859791.91267973,1.1054228565476594,0.14459834821206963,0.6853794746039993,0.7767634045511992,Upregulated
Feature0933,NA,C23 H41 N,331.32396,NA,NA,Feature0933,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,60160278.48004016,97111137.83916266,1.614206920125577,0.6908255250251554,0.5677197714431081,0.6864025684904821,Upregulated
Feature0932,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,6843183.45864353,27381029.703919467,4.001212282177657,2.0004371721278145,0.06278078256784073,0.2524949108355725,Upregulated
Feature0931,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,74172493.91200203,8700100.254778877,0.11729550667529992,-3.091780346835734,0.01156944041268394,0.1733067798896166,Downregulated
Feature0930,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,252266.43535047094,643897.633765897,2.552450677282284,1.3518830832077737,0.15906526412569716,0.31789769480536323,Upregulated
Feature0929,NA,C9 H15 N O7,249.08488,NA,NA,Feature0929,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,9158653.646232544,9637288.165046839,1.0522603580506817,0.07349171109004216,0.6397445484690917,0.7469233958192725,Upregulated
Feature0928,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,82950892.66528401,100686701.91954623,1.2138109510867854,0.2795437418836618,0.17421133147762105,0.33188069332072495,Upregulated
Feature0927,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,1743215.0191785733,3429241.321806572,1.9671935384210246,0.9761389012792203,0.3333260020774926,0.4810088122992096,Upregulated
Feature0926,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,75519122.02441509,60813918.276305534,0.8052784069264548,-0.3124404460050509,0.13209088555372467,0.30398802261806607,Downregulated
Feature0925,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature0925,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Phenol,3148973.4504759,748173.6269129557,0.23759286595442244,-2.073436576958675,0.029718658296413052,0.20988072323333595,Downregulated
Feature0924,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Phenol,9835754.54118603,17558312.805316865,1.7851515846388357,0.8360465846865907,0.015317190073933631,0.18680312242340796,Upregulated
Feature0923,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,450238.66141598095,833633.2265763816,1.851536302890208,0.8887228365666445,0.10802831238106812,0.2923176437002599,Upregulated
Feature0922,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,58435162.7961925,68542848.2764065,1.1729726588675233,0.23016938559493902,0.6416779026314712,0.7470187222362451,Upregulated
Feature0921,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,7952395.619784759,13284292.286307616,1.6704767873038955,0.7402599353372157,0.10096762035909737,0.29205985495082226,Upregulated
Feature0920,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1640573.58522466,2102476.215150227,1.2815494739678586,0.35788917466565084,0.6268529041966175,0.734163839779337,Upregulated
Feature0919,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,250392.61683092936,469120.758585198,1.873540699891957,0.9057673184166987,0.14884698205265673,0.31368398946706544,Upregulated
Feature0918,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,66276810.263200566,886978.3279023843,0.013382936269563788,-6.223461506023211,0.032737637434955086,0.21734691835514558,Downregulated
Feature0917,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Phenol,1349396.78645837,2055162.0511155934,1.5230227845062358,0.6069375247853349,0.13255832675621493,0.30398802261806607,Upregulated
Feature0916,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,817988.4492995983,929334.357022836,1.136121613720313,0.18411727332890457,0.7023535646636262,0.7894435400450703,Upregulated
Feature0915,NA,C5 H13 O6 P,200.04503,NA,NA,Feature0915,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,23636782.608974252,971994.371802618,0.041122109886206674,-4.603941901792609,0.2229888593922011,0.3749957127248786,Downregulated
Feature0914,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14903004.521891333,11449886.359331934,0.7682938257525829,-0.3802699351289398,0.199325529669552,0.35539505387094084,Downregulated
Feature0913,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Phenol,1298301.1433129627,4203624.646287057,3.237788603929273,1.6950087947761185,0.14720594982607071,0.31281264338040027,Upregulated
Feature0912,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,11417939.330439894,11802522.484017817,1.0336823609276533,0.04779292964144901,0.889303768474326,0.923890910498221,Upregulated
Feature0911,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,250804.85905767567,390802.326077885,1.5581928019505205,0.6398737553562919,0.2682152276900083,0.4127936358713356,Upregulated
Feature0910,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,15048562.600316932,34734891.8133046,2.308186684392904,1.206759912785827,0.009153189452438192,0.16564320267154278,Upregulated
Feature0909,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,72038442.40857577,16858011.5781616,0.23401410433819636,-2.095332609328467,0.003535006943289616,0.1302431386388236,Downregulated
Feature0908,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,8714266.46433791,20998394.378075268,2.409657136835175,1.268827884141181,0.14137321766774455,0.3094889519155126,Upregulated
Feature0907,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,15883201.2780117,15226010.842402166,0.9586235530163978,-0.06096370802613033,0.7395111523465814,0.8185590556721009,Downregulated
Feature0906,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,34695401.33494057,54708514.9029533,1.5768232329930767,0.6570209383921634,0.11948817709268435,0.2984601699370005,Upregulated
Feature0905,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,179635.444263619,345107.270241673,1.9211535432574232,0.9419728273031581,0.09123615927413187,0.28356501580491955,Upregulated
Feature0904,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,60758845.36970357,89679757.66681303,1.475995093737091,0.5616879258339916,0.046556896214941794,0.23233845289824126,Upregulated
Feature0903,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature0903,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,57573092.99556733,51935538.67885953,0.9020800512291073,-0.14867262993576638,0.06318303293851775,0.2524949108355725,Downregulated
Feature0902,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Phenol,780034.5135752549,823397.5850794594,1.0555912216056333,0.07805125824112426,0.8303195958328822,0.8772303074618585,Upregulated
Feature0901,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,15589444.4676257,22042857.5685201,1.4139604277943372,0.49974174431721924,0.11580498396491333,0.29530270911052897,Upregulated
Feature0900,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,574701.1288006577,765361.3069333173,1.3317553569636236,0.41332908412737873,0.5945981950059721,0.7067152275388779,Upregulated
Feature0899,NA,C12 H18 O9,306.09516,NA,NA,Feature0899,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4939370.635321846,6232250.048129943,1.2617498277133952,0.33542588964244424,0.37462078075267885,0.5138441515947502,Upregulated
Feature0898,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,453455.3417109457,823190.953351904,1.8153738144221612,0.8602666527301144,0.06023104085461213,0.2524949108355725,Upregulated
Feature0897,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,10005859.326148566,12293936.4783668,1.228673727826529,0.2971018614067567,0.1780912548436014,0.3347041673945071,Upregulated
Feature0896,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Phenol,13954298.202230666,1720736.6317237702,0.1233123018288875,-3.019611362444041,0.006515554455959405,0.1493750767119406,Downregulated
Feature0895,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,50221076.55492513,67037244.5877342,1.3348428426144505,0.4166698965740593,0.27488024508888864,0.41887020136556335,Upregulated
Feature0894,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,55720830.29160963,45332059.45312597,0.813556783269111,-0.2976850506714335,0.16673008511868873,0.3255755928817768,Downregulated
Feature0893,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,11902783.047762163,588101.7847503753,0.04940876284063197,-4.33908925756814,0.2091706063572717,0.36273480731508323,Downregulated
Feature0892,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,620741.4993685813,1258220.5853278232,2.026963859525561,1.0193203659887944,0.008103101776885254,0.1595031612923729,Upregulated
Feature0891,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,44689252.54036337,985773.94274391,0.02205841196053924,-5.502527258279799,0.03476465435142611,0.22518500080187337,Downregulated
Feature0890,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,11935382.3309547,22159711.501029033,1.8566402723067605,0.8926943173561013,0.0694890300922255,0.25816279289075317,Upregulated
Feature0889,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,9170047.621902866,22699246.288941868,2.4753684195406143,1.3076432635713522,0.36651725115014855,0.5064437879192939,Upregulated
Feature0888,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,51144548.8701103,20233638.709807836,0.39561672078082794,-1.3378246918495074,0.01650666607756285,0.1914215549792269,Downregulated
Feature0887,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Phenol,1477592.3556667145,2851565.3691240433,1.9298728490222656,0.9485057976861403,0.16373872962471397,0.32121736813208557,Upregulated
Feature0886,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,7169381.414333084,20897608.8369338,2.9148412714038527,1.5434173231535775,0.04128541031898076,0.2294308083870162,Upregulated
Feature0885,NA,C6 H15 N O6,197.08997,NA,NA,Feature0885,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,21427814.778204698,29799292.433362532,1.3906827523855994,0.47579334456656963,0.22066045406945764,0.3734253838098514,Upregulated
Feature0884,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,19592555.787089366,7255997.433904513,0.3703446101036954,-1.4330597541301016,0.05534893569048442,0.24513653722181605,Downregulated
Feature0883,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,57847806.0815107,54211928.02379403,0.9371475202950045,-0.09365192849043703,0.6843756162740907,0.7764099509196459,Downregulated
Feature0882,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,31549969.719391633,40889893.551249266,1.29603590478621,0.3741056865400421,0.07854234239278206,0.27115233281446605,Upregulated
Feature0881,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,12472035.691924367,10074612.455607563,0.80777610844482,-0.30797261873730725,0.22750228610399298,0.3780008505232887,Downregulated
Feature0880,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,8909701.791401394,9772496.689869294,1.0968376853309019,0.133350045436556,0.8248138888373213,0.8747081127367433,Upregulated
Feature0879,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Phenol,131402.07390875893,196244.92982016632,1.4934690449134922,0.578667335263292,0.13089693073831346,0.30398802261806607,Upregulated
Feature0878,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature0878,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,1882847.4831910732,1561196.80410255,0.8291679586583478,-0.27026372708673213,0.349378139155412,0.49308461903443046,Downregulated
Feature0877,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Phenol,695281.828640052,1037039.3410181394,1.4915381048380822,0.5768008351714249,0.0298411416068695,0.20988072323333595,Upregulated
Feature0876,NA,C30 H46 O11,582.30426,NA,NA,Feature0876,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,634040.875443785,1105056.8809306775,1.7428795582890673,0.8014728754516607,0.11402578956057054,0.29530270911052897,Upregulated
Feature0875,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,23674173.939590998,9591883.415051157,0.4051623275019694,-1.3034280580947335,0.0037632984008289065,0.1302431386388236,Downregulated
Feature0874,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature0874,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Phenol,36532207.64331743,32025063.762276597,0.8766254718289577,-0.18996749548244288,0.16093232713759137,0.3180083105610045,Downregulated
Feature0873,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,36083691.602779865,19374518.1759045,0.536932816885396,-0.897186510978011,0.0039524410686877995,0.1302431386388236,Downregulated
Feature0872,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,37007930.6624135,42647749.0461581,1.1523948592314184,0.20463512984342908,0.57625553106046,0.6922470084045355,Upregulated
Feature0871,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,110268.21933028306,211124.09484398033,1.9146413728837566,0.9370741895316225,0.17119101670596232,0.33116607024843053,Upregulated
Feature0870,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2204730.0791906733,1853292.52136525,0.8405983747659345,-0.2505114277377003,0.3295088763639322,0.4782780844506235,Downregulated
Feature0869,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,118537.3009208262,75877.26698886116,0.6401129973386296,-0.6436014924146684,0.10812105359679847,0.2923176437002599,Downregulated
Feature0868,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,31973281.992252834,7571571.067627836,0.23680931689973012,-2.078202252178029,0.2608500592426386,0.4071401879183212,Downregulated
Feature0867,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,236635.07863217534,396662.8261874157,1.6762638425386918,0.7452492459131739,0.18991920300096682,0.3475836870484041,Upregulated
Feature0866,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,16054184.503362333,9579730.321816366,0.5967123599339487,-0.7448924345845683,0.02426955919605581,0.202913517900705,Downregulated
Feature0865,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,13957374.633444099,10554008.465484753,0.7561600044893588,-0.40323655189761404,0.045304652086638565,0.23105372564185667,Downregulated
Feature0864,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,11951044.234889913,573435.0370558053,0.04798200272589716,-4.381362814085429,0.05005021611145976,0.23924543223939654,Downregulated
Feature0863,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,395451.65654113237,200505.22494579334,0.5070284107532574,-0.9798615056381316,0.5747841387782118,0.6922470084045355,Downregulated
Feature0862,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Phenol,25481322.165086,2442284.89156435,0.09584608191606007,-3.383136732485414,0.07252276979519201,0.2645078524992803,Downregulated
Feature0861,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature0861,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,719874.5114559947,1106953.609558527,1.5377035746405838,0.6207774196762892,0.10234970410396259,0.29205985495082226,Upregulated
Feature0860,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,372666.6195937167,682915.8236127524,1.8325113860674487,0.8738221623820127,0.36003300279535383,0.5005663310240236,Upregulated
Feature0859,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature0859,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,190364.38120247368,349458.30097632,1.835733653369914,0.8763567532849674,0.09687208719459295,0.29061626158377885,Upregulated
Feature0858,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,2270045.2567781466,824249.1341929863,0.36309810640640494,-1.461568688531155,0.13702690908133972,0.30398802261806607,Downregulated
Feature0857,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,8740050.26226658,27097337.13608657,3.1003639936802085,1.6324376029349894,0.023357042188381028,0.202913517900705,Upregulated
Feature0856,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,46854972.643469565,41093874.9456133,0.8770440494823506,-0.18927879112976267,0.3390697951034651,0.48514545619212557,Downregulated
Feature0855,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,209926.53000402398,144147.200709097,0.6866554727805672,-0.542341681995571,0.22397941615952674,0.3750819476581926,Downregulated
Feature0854,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4851848.11400986,8884428.390756603,1.831143140095945,0.8727445707283885,0.12563090754576958,0.30136820559300176,Upregulated
Feature0853,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,3021196.0338315233,3328329.6283920365,1.1016596047132374,0.1396785229532516,0.6737154519857516,0.7681999361057045,Upregulated
Feature0852,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,3585310.399330277,7889968.063531671,2.2006373743833976,1.1379214345161799,0.35178358439451984,0.4946130096374076,Upregulated
Feature0851,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,2676162.29547632,2153332.6115700398,0.8046345377520447,-0.3135944300356782,0.740496828437774,0.8185590556721009,Downregulated
Feature0850,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Phenol,9137520.46373254,4458918.280598533,0.4879790199426959,-1.035108972663309,0.004054315070686002,0.1302431386388236,Downregulated
Feature0849,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Phenol,379449.6960157727,374600.68627916067,0.9872209418335903,-0.01855509630864564,0.9639958490095288,0.9770581233863517,Downregulated
Feature0848,NA,C18 H33 N O15,503.18514,NA,NA,Feature0848,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,2774357.0117483465,2441569.4061325034,0.8800487449140056,-0.18434465966233257,0.19406722460112477,0.3514415367485534,Downregulated
Feature0847,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,12435767.74014322,27130273.6109453,2.1816323831272233,1.1254080202128594,0.01667493052861943,0.1914215549792269,Upregulated
Feature0846,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,14216150.937672967,29425626.6369981,2.0698729751820406,1.0495422345371834,0.0028253172882688835,0.1302431386388236,Upregulated
Feature0845,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,293618.59999279934,523900.68545937067,1.7842898422382598,0.8353499874528457,0.28060214195467326,0.42487935664391824,Upregulated
Feature0844,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Phenol,1052772.962359587,1054420.2193517566,1.0015646839832186,0.0022555976342290784,0.9968063610243123,0.9985863723832843,Upregulated
Feature0843,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature0843,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,544509.638434968,922250.780321094,1.693727190893868,0.7602015180940362,0.0692169815291333,0.25816279289075317,Upregulated
Feature0842,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,20629457.513230734,21655463.862935368,1.049735013586596,0.07002519186082566,0.5898157173730443,0.7022568246674081,Upregulated
Feature0841,NA,C14 H31 N O,229.24056,NA,NA,Feature0841,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,33084879.8868149,38574056.71421888,1.1659119466711905,0.22145883579596215,0.8097428663537587,0.8677473696742286,Upregulated
Feature0840,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,2063436.5024424433,1143682.152039177,0.5542608898725142,-0.8513628840830396,0.27497291409097135,0.41887020136556335,Downregulated
Feature0839,NA,C12 H19 N O7,289.11624,NA,NA,Feature0839,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,1287638.72386649,1152215.1934278668,0.8948280073218234,-0.16031768271031233,0.06130305275001581,0.2524949108355725,Downregulated
Feature0838,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,12811483.093814684,7927935.229225877,0.6188147906976861,-0.6924204148890553,0.11118819368293192,0.29530270911052897,Downregulated
Feature0837,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3294905.8421347835,1468547.4989184532,0.44570241739198685,-1.1658473090546468,0.07620464510973907,0.26632745741913066,Downregulated
Feature0836,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature0836,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,1576068.33382196,1207361.3305140065,0.7660589992225525,-0.3844725870609346,0.08649485536247463,0.28184191679182835,Downregulated
Feature0835,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,321266.2143279758,129335.90186581867,0.40258170980214436,-1.312646466038812,0.35167132902689396,0.4946130096374076,Downregulated
Feature0834,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature0834,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,4743821.75227725,6423142.55340265,1.3540016654966536,0.4372295135083934,0.5206903468050612,0.6455409603483743,Upregulated
Feature0833,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,32335702.876394067,51163491.38716103,1.5822600666123685,0.6619867464452488,0.05074903108108411,0.23924543223939654,Upregulated
Feature0832,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,2866914.9952669637,6384059.157993903,2.2268044809607015,1.1549748914299451,0.25812784942317457,0.4039322831977711,Upregulated
Feature0831,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,11894381.996793913,30330203.332735468,2.549960421727742,1.3504748549977668,0.022887100686888897,0.202913517900705,Upregulated
Feature0830,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,1854242.2382242733,532689.8434221123,0.28728168976036594,-1.799462050968301,0.006434698070206785,0.1493750767119406,Downregulated
Feature0829,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature0829,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,276676.7262548457,297904.608200073,1.0767244944400363,0.10664914927682845,0.821355459985261,0.8735173707141829,Upregulated
Feature0828,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,10705556.7630738,14992972.120123534,1.400485042668507,0.48592657535586675,0.07335500478362303,0.26478615200049554,Upregulated
Feature0827,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,11672789.1636994,17437929.503930934,1.4938956970250301,0.5790794234700277,0.17481416198979363,0.33188069332072495,Upregulated
Feature0826,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,955507.8760638126,1131546.5212699783,1.1842356820033255,0.24395622912625486,0.6667693134123384,0.7657268880743539,Upregulated
Feature0825,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,372097.6800791257,217402.347255629,0.584261496092636,-0.775313878728786,0.5138587787396032,0.6391901881882869,Downregulated
Feature0824,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,26826173.0728536,14276680.906471867,0.532192231359268,-0.9099806440185119,0.24491541669098485,0.3931260336584907,Downregulated
Feature0823,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Phenol,12126502.34338849,18082395.838462636,1.4911468555746719,0.5764223484168379,0.15978445377623027,0.31789769480536323,Upregulated
Feature0822,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,13015484.20381825,374021.1367546673,0.02873662868761684,-5.120965371575459,0.18636856519150333,0.34505863060209035,Downregulated
Feature0821,NA,C12 H19 N O8,305.11113,NA,NA,Feature0821,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,16466209.827336933,21245975.463128034,1.2902772214074312,0.36768106795987016,0.2556110161663953,0.40187006826893035,Upregulated
Feature0820,NA,C18 H33 N O15,503.18519,NA,NA,Feature0820,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,11565165.890241833,7167130.67266182,0.6197170659444775,-0.6903183966852249,0.27969269817610376,0.42407460453187623,Downregulated
Feature0819,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,7611059.2013070695,10853272.300792806,1.4259871081976265,0.5119609389883754,0.20790708440215497,0.3618105232088343,Upregulated
Feature0818,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,25214202.383601833,18073564.45257947,0.7168009591425224,-0.48035552703811374,0.1805692663040933,0.337317507574313,Downregulated
Feature0817,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Phenol,5122669.962106023,10716306.95653229,2.0919378050516886,1.0648399597696865,0.076311493491932,0.26632745741913066,Upregulated
Feature0816,NA,C7 H17 N O6,211.10558,NA,NA,Feature0816,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,6337937.273637567,7461965.767711687,1.17734926136765,0.23554236022163164,0.2960433286677819,0.4405313193173094,Upregulated
Feature0815,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Phenol,28478719.232754666,21160787.807638735,0.7430386048857406,-0.4284909263437381,0.27579396849881754,0.4192965212136494,Downregulated
Feature0814,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,17068127.552935068,19052365.119000234,1.1162539686858592,0.15866530465734222,0.28317471637449687,0.42704574162928155,Upregulated
Feature0813,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,1481424.8751327521,2104152.1583988667,1.4203569777443565,0.5062535672633646,0.3870962217076144,0.5251134959089786,Upregulated
Feature0812,NA,C32 H36 O10,580.23105,NA,NA,Feature0812,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,236666.370179821,402752.24434609164,1.7017721784471416,0.7670379118628625,0.12887518963257982,0.30288690529752293,Upregulated
Feature0811,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1292215.0674037763,3111703.5075382167,2.40803840322805,1.2678584002807,0.17001941477042065,0.3294676742183281,Upregulated
Feature0810,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Phenol,251662.93935451,360803.28381601867,1.4336766658668243,0.5197196926954498,0.1803398168574922,0.337317507574313,Upregulated
Feature0809,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1019691.7528754696,1752303.5786442165,1.718464010033253,0.781119637517453,0.0819635349835155,0.27545152412041163,Upregulated
Feature0808,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature0808,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,330004.43827884266,600462.1829874896,1.819557900855016,0.8635879604663661,0.15109815265823937,0.31604977772306975,Upregulated
Feature0807,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,1831382.0467527534,1482546.3779556733,0.80952326718742,-0.3048555480550043,0.03017335372063295,0.20988072323333595,Downregulated
Feature0806,NA,C9 H19 N O3,189.13649,NA,NA,Feature0806,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1312925.75995004,917106.3926699046,0.6985211355018297,-0.5176243262499544,0.13566063477018933,0.30398802261806607,Downregulated
Feature0805,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,218190.857686151,342323.196352864,1.5689163147489287,0.6497684016899744,0.2286585202223515,0.3780008505232887,Upregulated
Feature0804,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,24967616.7253616,12679345.208185567,0.5078316183581169,-0.9775778727487783,0.23555473264955243,0.3819254480242743,Downregulated
Feature0803,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,4266210.768788647,1217742.29919892,0.28543885081999526,-1.8087463828111796,0.10291430266496693,0.29205985495082226,Downregulated
Feature0802,NA,C11 H17 N O5,243.11065,NA,NA,Feature0802,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,1797049.6162449638,1337025.6147877667,0.7440115190484038,-0.4266031370683558,0.39513008056633075,0.5334969318837823,Downregulated
Feature0801,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,6598305.85649967,4709088.65846782,0.7136814753485738,-0.48664776918695085,0.3444811520456478,0.48740901116942165,Downregulated
Feature0800,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,1072683.08535976,2967375.019623085,2.766311001005368,1.4679633598094233,0.27072647025687846,0.4143998630671455,Upregulated
Feature0799,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,36138508.10698517,38396479.4286121,1.062481033111339,0.08743708719815103,0.4734047846165946,0.6084308915690941,Upregulated
Feature0798,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Phenol,13821811.837702902,21102092.8573215,1.526724072437419,0.6104393448480543,0.2290914245595689,0.3780008505232887,Upregulated
Feature0797,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,2024721.1986163668,531738.4061874143,0.26262302511120456,-1.928934686815254,0.1025687334346608,0.29205985495082226,Downregulated
Feature0796,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1303957.775935771,11124844.463509139,8.531598698067901,3.0928161070376796,0.04287422879265766,0.2294308083870162,Upregulated
Feature0795,NA,C7 H17 N O6,211.10569,NA,NA,Feature0795,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,5632350.034322296,2697882.6408288237,0.4789976873575902,-1.06190940436597,0.40757874202164107,0.5444087482717634,Downregulated
Feature0794,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,4805893.76977429,1512815.1105963234,0.31478330214264666,-1.6675690805823613,0.1569177986972814,0.31780102913059516,Downregulated
Feature0793,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,13317533.9336793,9291321.182335118,0.6976758030882794,-0.5193712961741008,0.1535611543025253,0.31604977772306975,Downregulated
Feature0792,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,2576210.94529568,4887088.02156693,1.8970061556842053,0.9237243602257552,0.17219681442907428,0.33139764286350143,Upregulated
Feature0791,NA,C15 H27 N O5,301.18898,NA,NA,Feature0791,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,929788.2121723803,4058972.3836294967,4.365480579868842,2.1261404836437254,0.04294159515265009,0.2294308083870162,Upregulated
Feature0790,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Phenol,14760556.075276956,22509277.566404853,1.5249613531909234,0.608772681189428,0.6157918524813764,0.7234748256378055,Upregulated
Feature0789,NA,C31 H40 O6,508.28264,NA,NA,Feature0789,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Phenol,124518.67941910363,229656.95616161433,1.8443574669519054,0.8831183010050193,0.09897103826887084,0.2909412949178688,Upregulated
Feature0788,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,1563170.4545707565,2055681.37285671,1.3150717932557112,0.3951415622146836,0.3661960740480904,0.5064437879192939,Upregulated
Feature0787,NA,C6 H9 O7 P,224.00856,NA,NA,Feature0787,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,7797635.931120917,4814805.01682294,0.6174698407765759,-0.6955594223595241,0.1516186893059941,0.31604977772306975,Downregulated
Feature0786,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,14703527.806579923,262946.748985465,0.01788324220176566,-5.805247871353547,0.25093352109504263,0.3982283036331511,Downregulated
Feature0785,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,3373647.2195300334,6920172.657797573,2.0512437156252483,1.0364989137754645,0.11570406430529216,0.29530270911052897,Upregulated
Feature0784,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,14928513.786525933,21680623.745565735,1.452296193418401,0.5383357186212889,0.46241482816326024,0.6004970337953449,Upregulated
Feature0783,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature0783,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,141454.04071053577,252554.57297215398,1.7854178763897497,0.8362617760130043,0.11031320761306494,0.29530270911052897,Upregulated
Feature0782,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,5744537.754030527,8743837.930384293,1.522113406644316,0.606075852342244,0.11398342154832158,0.29530270911052897,Upregulated
Feature0781,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature0781,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,32442671.63011433,24769013.1738995,0.7634702054225432,-0.3893562382291787,0.13631075960242703,0.30398802261806607,Downregulated
Feature0780,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Phenol,107819.1226927442,113588.11488153,1.0535062059930305,0.0751988128063796,0.6801592310070861,0.7731901288651981,Upregulated
Feature0779,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,6682971.596449307,14977247.7707925,2.241106004213751,1.1642108898731176,0.013135967300945019,0.1754589918054799,Upregulated
Feature0778,NA,C11 H14 N O P S,239.05347,NA,NA,Feature0778,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,194092.30749008767,243843.81977382733,1.2563291298202557,0.329214467220129,0.14296229067205485,0.30965963346340836,Upregulated
Feature0777,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,29136705.151380602,53158964.961274564,1.824467271954245,0.8674752714963591,0.04128825385312965,0.2294308083870162,Upregulated
Feature0776,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature0776,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,28262747.3261123,29392352.9834119,1.0399680060917484,0.05653914551755283,0.8657311035267488,0.9078040169691701,Upregulated
Feature0775,NA,C4 H11 O6 P,186.02935,NA,NA,Feature0775,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,17776676.7961467,20471388.998608734,1.1515869492011097,0.20362334421411724,0.655427133838109,0.7573524656708119,Upregulated
Feature0774,NA,C13 H19 N O6,285.1213,NA,NA,Feature0774,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Phenol,408357.8557775607,369451.8050842567,0.9047255975540807,-0.1444478044337774,0.7157875751679079,0.7983237170361756,Downregulated
Feature0773,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,11197864.309641046,8524101.981781714,0.7612256896560804,-0.3936038447388577,0.5744230095127527,0.6922470084045355,Downregulated
Feature0772,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,6092711.411056063,15033079.03127874,2.467387344819771,1.3029842160777845,0.3054103849755012,0.45028968717807144,Upregulated
Feature0771,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,861902.5394135483,1333390.4938318124,1.5470316339235661,0.6295026975225932,0.4829931216744898,0.6158162301349744,Upregulated
Feature0770,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,16660753.662814101,17804378.236130934,1.0686418271623175,0.09577839116598037,0.5197488236408858,0.645086482439241,Upregulated
Feature0769,Furan,C4 H4 O,68.02622,Other,NA,Furan,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,17518109.857934933,17163056.930809766,0.9797322353835826,-0.02954058593342745,0.8752435542143906,0.9135100165846941,Downregulated
Feature0768,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,3339707.04269075,1202167.4015902667,0.3599619326555359,-1.4740837507572806,0.06063497561602302,0.2524949108355725,Downregulated
Feature0767,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,2634344.0597624667,2237154.1786836,0.8492262695880809,-0.23577909526645868,0.336105572284548,0.4833186502690492,Downregulated
Feature0766,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1328506.0702837142,2346147.2654784434,1.7660041741302717,0.8204887529466995,0.11572369070190051,0.29530270911052897,Upregulated
Feature0765,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,1591202.1506800633,1087648.5222165633,0.6835388713820639,-0.5489047117662768,0.12613813708652108,0.30136820559300176,Downregulated
Feature0764,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Phenol,2444567.2781775966,1922381.2324251332,0.7863891698076936,-0.3466846419427494,0.378464269322776,0.5167979258499203,Downregulated
Feature0763,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,6285503.032914303,3582396.088460237,0.5699458054034606,-0.8111033510359702,0.041104972340500145,0.2294308083870162,Downregulated
Feature0762,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3784513.43723092,5465431.284849693,1.4441569241325456,0.5302275160251156,0.2488658679934952,0.39710778173245215,Upregulated
Feature0761,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Phenol,236296.111644129,304793.65312731604,1.2898801042750418,0.3672369718449772,0.3969735871632814,0.5346991174036035,Upregulated
Feature0760,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,916860.9060775621,1190722.0707206957,1.2986943415602084,0.3770619205437511,0.7021246670825433,0.7894435400450703,Upregulated
Feature0759,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,3897084.6737683634,10508294.262587186,2.696450075442159,1.4310613227122637,0.062488193686125355,0.2524949108355725,Upregulated
Feature0758,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,515795.7749504643,955598.2004679274,1.852667755100748,0.8896041813944994,0.0665962263343585,0.2532914099903398,Upregulated
Feature0757,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,2382628.6344733573,782136.128810255,0.3282660660976795,-1.607062473221644,0.2919631986274238,0.436776945146626,Downregulated
Feature0756,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4440859.277566744,3976854.5469439332,0.8955146511922237,-0.15921105906981176,0.7006809479734022,0.7894435400450703,Downregulated
Feature0755,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0755,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,1493870.2451069765,1343408.6074346134,0.8992806516059978,-0.153156666029811,0.7149722342997744,0.7982078078451212,Downregulated
Feature0754,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,1475491.3273642699,409544.3638886743,0.2775647381271024,-1.849103795560623,0.37915421693935364,0.5169028328140398,Downregulated
Feature0753,NA,C18 H28 O,260.21405,NA,NA,Feature0753,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1240029.0918568387,2082528.7626586433,1.6794192784140514,0.747962453845439,0.12568494807600064,0.30136820559300176,Upregulated
Feature0752,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Phenol,113898.21335687733,167094.88234968265,1.467054464025034,0.5529224316931484,0.23214462956666143,0.38135618502751706,Upregulated
Feature0751,NA,C13 H18 O9,318.09513,NA,NA,Feature0751,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,129324.37045032273,46199207.22964877,357.2351218009233,8.480730116698329,0.021461389950921183,0.20138456856034048,Upregulated
Feature0750,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,1547521.5076384866,1327574.7317998568,0.85787158708103,-0.22116638486222118,0.27758075590591863,0.4214419595756978,Downregulated
Feature0749,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4221423.178315717,6759693.595291237,1.601283100451505,0.6792283931203451,0.06720048838807767,0.25472617557913224,Upregulated
Feature0748,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,24838710.78778953,23029511.748604666,0.9271621198603331,-0.10910647009389463,0.46996233422690264,0.6061138177748706,Downregulated
Feature0747,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature0747,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,14902379.955123367,19250711.755620334,1.2917877421989923,0.36936903564035795,0.17640511541296444,0.33320966244671063,Upregulated
Feature0746,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature0746,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,4308041.204835377,2688290.5048089633,0.6240168970045148,-0.6803430002636599,0.06374739177313979,0.2524949108355725,Downregulated
Feature0745,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,12078440.377236757,11771544.970023347,0.9745914706180285,-0.037130498409789665,0.9246712897963829,0.948337465403603,Downregulated
Feature0744,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Phenol,608647.0139041137,2133001.59129736,3.504496929370286,1.8092073601865681,0.10725742331538819,0.2923176437002599,Upregulated
Feature0743,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,315270.571792814,453518.3824050877,1.4385052808009173,0.5245705172685877,0.037973992185231994,0.2294308083870162,Upregulated
Feature0742,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,220462.283964317,443166.2121340827,2.010167926073974,1.007316026774663,0.03031374982543846,0.20988072323333595,Upregulated
Feature0741,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,7351443.086696863,14554270.202923067,1.9797841092261743,0.9853431164006471,0.003266587873125596,0.1302431386388236,Upregulated
Feature0740,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,4370130.769517093,7396523.04617964,1.6925175552577272,0.7591707979077553,0.5492647767996712,0.6691368942119774,Upregulated
Feature0739,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,228413.328176365,4864802.080252999,21.298240864897057,4.412662370395023,0.17422104472440902,0.33188069332072495,Upregulated
Feature0738,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1014774.285664735,1895232.7900213366,1.8676397468820873,0.9012161972799609,0.05030164250421037,0.23924543223939654,Upregulated
Feature0737,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,2333354.562866962,4033031.384510329,1.7284262960683507,0.7894590851948879,0.6634096121696295,0.7631430008335496,Upregulated
Feature0736,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,10446262.820064576,8229438.243951494,0.7877877845601267,-0.34412104819582673,0.041222909936772745,0.2294308083870162,Downregulated
Feature0735,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,7631480.8622159995,13943910.8794428,1.8271566333187164,0.86960031454889275,0.026216902359493,0.2042456212056748,Upregulated
Feature0734,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,2426433.2839538935,6568276.456416761,2.7069676713771824,1.436677657917737,0.041805453365161616,0.2294308083870162,Upregulated
Feature0733,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0733,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,21809632.7863606,16658378.134161966,0.763808281292102,-0.3887175329862701,0.031209266503685818,0.20988072323333595,Downregulated
Feature0732,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,747892.8203202327,1126656.85488618,1.5064415973451493,0.5911447427274145,0.20115762124897307,0.35539505387094084,Upregulated
Feature0731,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,17722084.145549603,11153386.270822434,0.6293495832217504,-0.6680664849661485,0.11694313905359134,0.2961855576030011,Downregulated
Feature0730,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,7337734.422690333,12067007.447770992,1.644514062877013,0.7176613452704146,0.030375535838758107,0.20988072323333595,Upregulated
Feature0729,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,871435.9750904327,1541288.8574988693,1.76867710486582,0.8226706892218475,0.4012609312758665,0.5394345985328356,Upregulated
Feature0728,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,3941691.88111353,361633.3249304957,0.09174571119149326,-3.4462154714633755,0.15142618333908206,0.31604977772306975,Downregulated
Feature0727,NA,C29 H30 O10,538.18408,NA,NA,Feature0727,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,350238.05621094664,611945.6497222154,1.747227746586292,0.8050676720529805,0.14714194636590688,0.31281264338040027,Upregulated
Feature0726,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Phenol,10139235.926685331,15221873.892311,1.5012841206553578,0.5861970353669661,0.008802930405503038,0.16545908274686147,Upregulated
Feature0725,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,29180957.838676333,28142536.481404234,0.9644144183678652,-0.052274874937878954,0.8056641297722547,0.8650288551238945,Downregulated
Feature0724,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2487793.50721406,4072545.1612451603,1.637010929337851,0.7110639538517011,0.1110244772937281,0.29530270911052897,Upregulated
Feature0723,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Phenol,5270894.486921307,2551783.3408217635,0.4841271907744529,-1.046541970129144,0.11231934440815614,0.29530270911052897,Downregulated
Feature0722,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,7811031.380019766,19358591.077476468,2.4783655493940007,1.3093889951472086,0.048631530449122946,0.23924543223939654,Upregulated
Feature0721,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,3734909.36480916,10761130.538258553,2.8812293652026564,1.5266845132811862,0.017848357626468473,0.1914215549792269,Upregulated
Feature0720,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,24118215.4354955,24511770.01981313,1.0163177323533825,0.02335150371391988,0.8031808292526708,0.8640161940762192,Upregulated
Feature0719,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,5413932.1547114635,7793535.791861286,1.4395333316245897,0.5256011941203662,0.1501166440332487,0.31482406468281315,Upregulated
Feature0718,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature0718,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,22886068.3715825,27130463.739970133,1.1854576023926362,0.24544406609981576,0.1592317271890798,0.31789769480536323,Upregulated
Feature0717,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,8378278.696594346,380137.0172819447,0.04537173219559587,-4.462062450026742,0.14116559679110782,0.3094889519155126,Downregulated
Feature0716,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,125112.40155444543,201267.40818248165,1.6086927089709464,0.6858887700744019,0.13492029917128784,0.30398802261806607,Upregulated
Feature0715,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature0715,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,10723948.2145859,8217420.7930075135,0.7662682277624953,-0.3840786072718296,0.06593822147752643,0.2532914099903398,Downregulated
Feature0714,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,6239692.193596397,8307425.792629354,1.3313839104363205,0.41292663873300495,0.1822202647059792,0.3390566119404787,Upregulated
Feature0713,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,195682.74058957933,223001.65324734134,1.1396081870861574,0.18853789131123133,0.7915530184403827,0.8595908313223575,Upregulated
Feature0712,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,10078426.742309617,9843331.984390726,0.9766734666104231,-0.034051791489007284,0.7960025612690993,0.8595908313223575,Downregulated
Feature0711,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,23624802.308456134,12347776.960375734,0.5226615994139361,-0.9360509282625947,0.019449248901632677,0.1914215549792269,Downregulated
Feature0710,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,26413015.1336038,24560785.698258765,0.9298743658769745,-0.10489228616136763,0.4840440267507066,0.6164556163612859,Downregulated
Feature0709,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature0709,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1103364.169572668,2183069.2689399733,1.978557333237923,0.9844488713149598,0.11130021191749506,0.29530270911052897,Upregulated
Feature0708,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1435147.563337297,1658441.5869787482,1.15558959186204,0.20862911504091775,0.819725257042437,0.8726107574967877,Upregulated
Feature0707,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,3939991.98210936,6509331.735939583,1.6521180158480098,0.7243167465620782,0.04167225815285642,0.2294308083870162,Upregulated
Feature0706,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6942308.60078755,4727730.1476066895,0.6810025914247554,-0.5542678067402801,0.08883727605904827,0.28184191679182835,Downregulated
Feature0705,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Phenol,583837.9129803313,673504.1995103997,1.1535807876407798,0.20611904246687476,0.5321972915941795,0.6561817155699664,Upregulated
Feature0704,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature0704,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,13801411.456524476,10655814.978979643,0.7720815376417327,-0.3731748798556154,0.7701479476407731,0.8405818194811752,Downregulated
Feature0703,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Phenol,168770.16621850934,304977.3968543153,1.807057513111982,0.8536424235024717,0.21072386804068768,0.363742577638667,Upregulated
Feature0702,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,559810.9722604023,3137323.4276940767,5.604254977401043,2.4865225957158645,0.09890670504672264,0.2909412949178688,Upregulated
Feature0701,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,6844491.322364833,16476871.7164444,2.40731866553839,1.267427129249905,0.05585140544733505,0.24513653722181605,Upregulated
Feature0700,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Phenol,2162376.111941113,10708555.120095747,4.952216712421473,2.3080744492643688,0.03602204260304881,0.22788765113960638,Upregulated
Feature0699,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,3580392.5155365635,6903688.817809917,1.9281932882644626,0.947249679183759,0.012300531825611567,0.1733067798896166,Upregulated
Feature0698,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature0698,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,1266239.8441197986,1097686.8395167156,0.8668869840213809,-0.20608417320459252,0.5234701947676441,0.648271035904301,Downregulated
Feature0697,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,136229.435832708,172932.83585190267,1.2694234164213016,0.3441733606554183,0.41163729011531336,0.5478731192282106,Upregulated
Feature0696,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature0696,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Phenol,532053.1025504853,984919.074355267,1.8511668659272789,0.8884349469617763,0.1455420668790341,0.311044188694344,Upregulated
Feature0695,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,2850178.88748823,1260733.78367129,0.4423349668351286,-1.1767888022649236,0.189861087198491,0.3475836870484041,Downregulated
Feature0694,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Phenol,21642212.711967766,16640857.524516,0.7689074008275455,-0.3791182293540992,0.10301261066604281,0.29205985495082226,Downregulated
Feature0693,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,4988757.33030108,4708487.10319901,0.9438196311133948,-0.0834169155556463,0.6638391878908596,0.7631430008335496,Downregulated
Feature0692,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature0692,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,790433.719977719,475427.49007119366,0.6014767311351484,-0.7334191688330862,0.10730207031141185,0.2923176437002599,Downregulated
Feature0691,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Phenol,249819.42975307832,351721.0448984757,1.407901079776369,0.49354597266166134,0.3664010972905631,0.5064437879192939,Upregulated
Feature0690,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,3900834.4300859496,3082318.0561209866,0.7901689013888938,-0.3397670274820545,0.4183557068750843,0.5535319612191564,Downregulated
Feature0689,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,7307706.353234463,13236221.7855232,1.8112689735630547,0.8570008025065421,0.011296721057619653,0.1733067798896166,Upregulated
Feature0688,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,17648733.963040866,3419496.3712002235,0.19375306910745943,-2.3677089315918796,0.005947309064743998,0.1493750767119406,Downregulated
Feature0687,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature0687,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,474686.30055668805,441868.77641930635,0.9308648172511088,-0.10335642403344071,0.5538335356311919,0.6732407659568768,Downregulated
Feature0686,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature0686,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Phenol,20422361.007440433,18818914.409140132,0.9214857382201734,-0.11796625736371388,0.5361863620085091,0.6589278183719027,Downregulated
Feature0685,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,4287062.905616663,4092708.311720187,0.9546648607274122,-0.0669337372622175,0.6418235724026206,0.7470187222362451,Downregulated
Feature0684,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3590723.407071347,7728440.103798427,2.1523351223818907,1.105902725551225,0.0656292762508746,0.2530448383281144,Upregulated
Feature0683,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Phenol,235851.05119322732,403486.2841601937,1.710767376778095,0.7746436013324898,0.12714485732116051,0.30136820559300176,Upregulated
Feature0682,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,8648866.601740938,10825128.452731544,1.2516239353897012,0.32380115328706277,0.2495195954735996,0.39710778173245215,Upregulated
Feature0681,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Phenol,2759233.0086197634,4360443.05107081,1.5803098315542448,0.660207437279499,0.028421916877869716,0.20988072323333595,Upregulated
Feature0680,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Phenol,1978590.4267642633,2675317.0173863266,1.35213280181562,0.4352368551051047,0.46922094275931636,0.6061138177748706,Upregulated
Feature0679,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,9954772.373984937,10161153.62454885,1.0207318904752916,0.029603971919416616,0.9725783990992647,0.9822078881992574,Upregulated
Feature0678,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,9902845.924888054,11847126.902598865,1.196335577919515,0.2586221292455804,0.12444902432137132,0.30136820559300176,Upregulated
Feature0677,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0677,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,133108.22366005316,299102.12287327467,2.2470596830828087,1.1680384437630773,0.024544494167825715,0.202913517900705,Upregulated
Feature0676,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,18918793.890794165,7752587.159011464,0.4097823150757962,-1.287070371404456,0.03678279986602893,0.22796760781090802,Downregulated
Feature0675,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,6387627.131099683,8282958.03127491,1.2967190885246507,0.374865978828992,0.20208738357367223,0.35539505387094084,Upregulated
Feature0674,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,408881.6069422947,820211.4738083864,2.0059876988405168,1.0043127590526872,0.19050703412854728,0.3475836870484041,Upregulated
Feature0673,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0673,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,12823097.24551199,3685462.5028544734,0.28740813801005555,-1.798827182359584,0.02992812051409615,0.20988072323333595,Downregulated
Feature0672,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,6553007.200203817,12270232.011649067,1.8724581916020826,0.9049335064321082,0.35869657541011113,0.5001005584546228,Upregulated
Feature0671,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,645189.9556541783,1106138.6554547786,1.714438741274622,0.7777363561614393,0.08181918244982561,0.27545152412041163,Upregulated
Feature0670,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,9122457.698245954,14168107.366653966,1.5531020077383508,0.6351525890460203,0.2743814868256098,0.41887020136556335,Upregulated
Feature0669,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,10515573.760662444,15062784.173943466,1.4324262771368326,0.5184608895259453,0.051549355720074345,0.23999326604947477,Upregulated
Feature0668,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0668,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Phenol,8121275.46531626,3874539.4442430167,0.4770850909798728,-1.0676814924165001,0.05450376540045737,0.24513653722181605,Downregulated
Feature0667,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0667,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,2184497.9282775465,2319418.45319315,1.0617627158941674,0.08646138680879269,0.79040003806895065,0.8595908313223575,Upregulated
Feature0666,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0666,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,2916871.1529228534,1142824.2622744385,0.39179799256105996,-1.3518180891389913,0.07962374706731906,0.2740424669004049,Downregulated
Feature0665,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0665,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,4744707.14027695,3268068.9988476867,0.6887820264196387,-0.5378805983976325,0.06494553077868165,0.2524949108355725,Downregulated
Feature0664,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,17644129.076620165,18038544.953571267,1.0223539442065028,0.03189475121612778,0.9032924499028729,0.9324903924437005,Upregulated
Feature0663,NA,C9 H19 N O9,285.106,NA,NA,Feature0663,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,12113336.061901763,7446094.787483186,0.6147022380483819,-0.7020403571483887,0.23991637641315386,0.3878763318956176,Downregulated
Feature0662,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0662,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,8503210.892765714,9082252.087834356,1.0680967698403523,0.09504236148639443,0.6566237242502855,0.7574243162173012,Upregulated
Feature0661,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,587051.396003852,749488.007683605,1.2766991319422518,0.3524185782932269,0.4167638018186871,0.5527292974474787,Upregulated
Feature0660,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,1277346.0278490388,291710.4248337127,0.22837228008211102,-2.130540548455693,0.21079546052998455,0.363742577638667,Downregulated
Feature0659,NA,C19 H41 N O2,315.3138,NA,NA,Feature0659,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,10468141.230016967,272002.49616240733,0.025983838982077477,-5.266241592274392,0.34019660936243346,0.4856241675631684,Downregulated
Feature0658,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,17762838.367039565,18703560.1113533,1.0529601027085471,0.07445077281662643,0.11634726724238194,0.29601277516089014,Upregulated
Feature0657,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0657,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,91068.72825440357,178626.25032432168,1.9614444359574585,0.9719164671488679,0.018037462441747393,0.1914215549792269,Upregulated
Feature0656,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,4688827.501723477,9765257.523857107,2.0826651268931693,1.0584308861336993,0.07339176008956393,0.26478615200049554,Upregulated
Feature0655,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Phenol,19044403.423702918,24516356.7059875,1.2873260537777789,0.3643775054562791,0.41093073415273107,0.5475822847023328,Upregulated
Feature0654,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,12492891.547885787,383620.20176091534,0.030707078524654017,-5.025284929121164,0.026902767127924124,0.20533948787435963,Downregulated
Feature0653,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,8574328.52546854,8551618.923611384,0.9973514425310739,-0.0038261298279084746,0.9909484455308664,0.994493878251907,Downregulated
Feature0652,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,468135.9463201237,1050804.8455915616,2.244657462969087,1.166495305019955,0.10174615086897439,0.29205985495082226,Upregulated
Feature0651,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,1389875.340454139,5503526.191985107,3.9597264817914106,1.9854007795494735,0.03361995070307793,0.22059406250791486,Upregulated
Feature0650,NA,C19 H41 N O2,315.31381,NA,NA,Feature0650,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,613553.4000021043,287360.364798199,0.4683542863542332,-1.0943278261970497,0.5488432625437817,0.6691368942119774,Downregulated
Feature0649,NA,C12 H21 N O8,307.12685,NA,NA,Feature0649,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1924661.2072642033,986507.7714621567,0.5125617785295425,-0.9642021932804743,0.13555783412178327,0.30398802261806607,Downregulated
Feature0648,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0648,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,846638.741824212,552066.5717802036,0.6520686386152046,-0.6169042602196904,0.3305933829417535,0.4792322682954101,Downregulated
Feature0647,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,693819.6620670717,556327.4149864434,0.8018328758931353,-0.3186265243484878,0.3414623938735582,0.48619391614991414,Downregulated
Feature0646,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0646,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Phenol,13494698.382192133,9738693.366148254,0.7216681018228331,-0.47059260672902825,0.01738959432891916,0.1914215549792269,Downregulated
Feature0645,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,470695.82868840767,465918.23988040036,0.9898499444507082,-0.01471825737681791,0.9885819476616929,0.9930071130496145,Downregulated
Feature0644,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0644,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,64807.40285344517,100549.02285752213,1.5515052051214382,0.6336685369506085,0.15426293135761937,0.31604977772306975,Upregulated
Feature0643,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,3715751.6916134236,5062946.981470797,1.3625633254498783,0.44632328103781793,0.25449454586431197,0.4010433714322444,Upregulated
Feature0642,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,11436717.947954936,11310803.2876633,0.9889903151529454,-0.01597170165750612,0.8992944827478089,0.929961667873771,Downregulated
Feature0641,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,16654300.723371867,19680151.3616231,1.1816858413037359,0.24084653683901283,0.5147870511771827,0.6396357380075293,Upregulated
Feature0640,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Phenol,412281.687027684,763354.5105342943,1.8515363028555676,0.8887228365396531,0.1080283124599065,0.2923176437002599,Upregulated
Feature0639,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0639,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,8962343.969523087,8907695.28420097,0.9939024115222588,-0.008823890307613708,0.9383696694851593,0.9586479233215527,Downregulated
Feature0638,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0638,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,4671421.372515197,1595096.0300360443,0.34145839196201844,-1.5502183036844825,0.019032175835434286,0.1914215549792269,Downregulated
Feature0637,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Phenol,717814.9429298594,2300537.9703834103,3.204917915185008,1.6802874068059364,0.09297685209651019,0.2873829973892133,Upregulated
Feature0636,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0636,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Phenol,1948355.5959330467,2491244.4066656833,1.2786394905867544,0.35460955706004454,0.18853028865601826,0.3475836870484041,Upregulated
Feature0635,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,271981.0981380763,632194.879992554,2.3244074103694086,1.2168629591925113,0.416072860864542,0.5527292974474787,Upregulated
Feature0634,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,609039.27083733,538994.5423354816,0.8849914416757588,-0.17626459123030586,0.7242580773412486,0.8069687813077269,Downregulated
Feature0633,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,18981113.537466798,28486836.647581432,1.5007990227418058,0.5857307935429464,0.03974587550006963,0.2294308083870162,Upregulated
Feature0632,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,3821712.802969597,3018652.7030746066,0.7898690609951156,-0.3403145817366397,0.19876842418333132,0.35539505387094084,Downregulated
Feature0631,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0631,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,167289.71586401068,312134.207502366,1.8658302208851796,0.8998177157552365,0.11533785223001063,0.29530270911052897,Upregulated
Feature0630,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,3215192.1220878633,3508439.83631115,1.091206902445649,0.12592467529273316,0.7691560526227856,0.8405818194811752,Upregulated
Feature0629,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,5044453.85960488,3077960.54357688,0.6101672508543807,-0.7127233458096763,0.03123893117644127,0.20988072323333595,Downregulated
Feature0628,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,3816791.5781159066,4749861.35806905,1.2444644306236228,0.3155249956895751,0.16279650555670042,0.32086406888399843,Upregulated
Feature0627,NA,C15 H27 N O13,429.14831,NA,NA,Feature0627,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,4093391.1886706734,2353880.238662083,0.5750440478733,-0.7982556254138935,0.5334178904597091,0.6569647344630006,Downregulated
Feature0626,NA,C6 H2 O4,137.99529,NA,NA,Feature0626,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,5556089.69188205,12012367.1409284,2.1620182191226247,1.1123786805781648,0.0022866778388205998,0.1302431386388236,Upregulated
Feature0625,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0625,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Phenol,498002.491486697,470511.5107213563,0.9447975035561141,-0.0819229421886726,0.8422266521525003,0.8881375034916402,Downregulated
Feature0624,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,498980.94933312165,698526.8624531473,1.3999068769794014,0.48533086103567896,0.23452093168418175,0.3819254480242743,Upregulated
Feature0623,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,6222915.88098755,2961623.7032202366,0.4759221817972316,-1.0712023976423986,0.025262151817255964,0.202913517900705,Downregulated
Feature0622,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0622,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4775383.665316587,5281649.13102645,1.1060156630737017,0.1453718167468943,0.35279300854599793,0.4954114588092737,Upregulated
Feature0621,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0621,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,111402.37201327336,194964.51066802067,1.7500929930360105,0.8074315832161436,0.15256217088308302,0.31604977772306975,Upregulated
Feature0620,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,231558.07300432265,432591.22067713033,1.868175939903658,0.901630330675903,0.061318702712217864,0.2524949108355725,Upregulated
Feature0619,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0619,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,1843371.64344536,4076791.169958813,2.211594815649368,1.1450870948862897,0.024047967533014115,0.202913517900705,Upregulated
Feature0618,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1008547.9255682023,1449049.4101977122,1.4367680240691958,0.5228271477096998,0.2751402303087524,0.41887020136556335,Upregulated
Feature0617,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0617,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,9294466.23298083,7647694.381289394,0.8228223320831518,-0.2813471445485857,0.08781586875240256,0.28184191679182835,Downregulated
Feature0616,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,16741144.1519005,14709152.231183734,0.8786228765322417,-0.18668403179864484,0.26396543726906546,0.4079465848703739,Downregulated
Feature0615,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,106112.41850963523,188738.71277412234,1.778667524734482,0.8307968617889074,0.105541118646738,0.2923176437002599,Upregulated
Feature0614,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,928338.424214224,1673084.3070473867,1.802235330788489,0.8497874064868526,0.06644676912194461,0.2532914099903398,Upregulated
Feature0613,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1853611.8149563132,3131658.3286751164,1.6894898400013298,0.7565876746663963,0.050088646439421625,0.23924543223939654,Upregulated
Feature0612,NA,C13 H27 N O11,373.15852,NA,NA,Feature0612,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,85755.15095546117,108118.084040674,1.2607765578633,0.3343126155344837,0.05559271019873909,0.24513653722181605,Upregulated
Feature0611,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,262987.049350979,1039661.2617127526,3.953279312720965,1.983049890103567,0.2169608749831826,0.37043217676559315,Upregulated
Feature0610,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,98783.5715934067,141136.37821140766,1.4287434229683977,0.5147468571990073,0.12458051244210934,0.30136820559300176,Upregulated
Feature0609,NA,C12 H21 N O8,307.12682,NA,NA,Feature0609,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,15453838.867875699,13950006.560595974,0.9026887545459155,-0.1476994600903873,0.7322350991105492,0.8128291348049507,Downregulated
Feature0608,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,231841.898763846,257428.68525114065,1.1103630820128736,0.1510315062759569,0.7478065272531742,0.82377953089506,Upregulated
Feature0607,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Phenol,3288055.93712647,6175053.600719787,1.8780257145249029,0.909216816965902,0.00710642172225835,0.15333471485334363,Upregulated
Feature0606,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,5596992.295959284,9009659.585399307,1.6097323542688775,0.6868208353785845,0.08171289752272318,0.27545152412041163,Upregulated
Feature0605,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,299197.900972618,293109.44143728,0.9796507277773474,-0.029660614148012226,0.9180787096356753,0.9424376140999339,Downregulated
Feature0604,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,15751045.132732535,12770132.219408533,0.810748246341488,-0.30267409677017193,0.4576850422169109,0.5957338948577425,Downregulated
Feature0603,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,198158.52062203933,318711.29214979435,1.6083653185809414,0.6855951325399339,0.2440540856796459,0.39230470506097803,Upregulated
Feature0602,NA,C12 H21 N O8,307.12679,NA,NA,Feature0602,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,740611.0280929847,373760.45359774097,0.504664985289437,-0.9866021019734004,0.11675867953415571,0.2961855576030011,Downregulated
Feature0601,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0601,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,10300685.30250945,5512860.59785868,0.5351935755687672,-0.9018672968278484,0.0049729498738499515,0.14353422199792465,Downregulated
Feature0600,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,319020.31972508965,582551.4316549547,1.8260637195679525,0.8687371083127075,0.005407396399998665,0.1493750767119406,Upregulated
Feature0599,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0599,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,12505588.2440842,11371701.965561938,0.9093296327696819,-0.13712472746870227,0.7598494620391673,0.8333832809461834,Downregulated
Feature0598,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1419090.7726021968,1457409.8410409468,1.0270025492227561,0.03843976271400867,0.8191859844169825,0.8726107574967877,Upregulated
Feature0597,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,153181.63200415613,225209.58163979434,1.47021270561789,0.5560248946130661,0.3133663118097606,0.4596039239876488,Upregulated
Feature0596,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,8125495.4503702605,5832426.254348624,0.7177933074939883,-0.47835962295968215,0.10737048870236933,0.2923176437002599,Downregulated
Feature0595,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14006114.5046046,14037386.132979,1.0022327126030648,0.0032175328222585633,0.9814291502064973,0.9877263249984356,Upregulated
Feature0594,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,470851.240851896,903012.8432567593,1.91783044178235,0.9394751751980303,0.07799249881683176,0.2700851347916211,Upregulated
Feature0593,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0593,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,6536083.813634723,4594180.190178807,0.7028949323744945,-0.5086190412520275,0.00972737746798712,0.16790950029356227,Downregulated
Feature0592,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,14683395.109169256,17108674.69595197,1.1651715811466663,0.22054241929364052,0.6438373953512683,0.7478111362154483,Upregulated
Feature0591,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2902666.7578373533,2089276.72787216,0.7197783632003235,-0.4743753599111361,0.08558780478875451,0.28184191679182835,Downregulated
Feature0590,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0590,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,3776729.3046521298,1990247.9617512699,0.5269765983227092,-0.9241891979838768,0.3040428113694052,0.44916331526364545,Downregulated
Feature0589,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,103762.68748050806,133669.92071738985,1.2882272420179932,0.3653871058867932,0.5125503952190006,0.638979492706354,Upregulated
Feature0588,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3450519.9977902067,2882073.6492816834,0.835257773068242,-0.2597065912692605,0.35880655040639153,0.5001005584546228,Downregulated
Feature0587,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,503510.02759201033,782257.935204686,1.5536094463614984,0.6356238778686206,0.13352498241538654,0.30398802261806607,Upregulated
Feature0586,NA,C17 H29 N O14,471.15895,NA,NA,Feature0586,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,5153068.019323247,1643631.6993810667,0.31896177058359987,-1.6485445758958106,0.05098410928216774,0.23934799420331465,Downregulated
Feature0585,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,1200765.5727047396,2585616.0461354,2.1533062780200027,1.106553537505358,0.08719409092219238,0.28184191679182835,Upregulated
Feature0584,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,873931.8498751316,1374129.23132614,1.5723528459598735,0.6529250038530764,0.05176909136459348,0.24002033269038794,Upregulated
Feature0583,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,8560353.60426367,6192736.40932997,0.7234206313913882,-0.4670933517711926,0.34421567044698903,0.48740901116942165,Downregulated
Feature0582,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,6356431.29656091,3098296.829585613,0.4874270931335196,-1.0367416508777259,0.025318977278162833,0.202913517900705,Downregulated
Feature0581,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,11123276.667460684,11948137.1434079,1.0741562491527528,0.1032038662115812,0.4267937160697635,0.5613863416533115,Upregulated
Feature0580,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,3141759.98650875,2011826.4036619633,0.6403501261398347,-0.6430671473902962,0.0094595353278272409,0.16790950029356227,Downregulated
Feature0579,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2505546.53306775,1526061.0274951067,0.6090731133325322,-0.71531267478355,0.031695606664225134,0.21168137307893214,Downregulated
Feature0578,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,13165100.2116255,14180672.5053226,1.0771412505314844,0.10720744958435653,0.6406047252725174,0.7470187222362451,Upregulated
Feature0577,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0577,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,9518777.265962703,7918841.135228493,0.8319178938606673,-0.26548694628693775,0.054064873877621156,0.24513653722181605,Downregulated
Feature0576,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,326913.927583951,579095.71761687,1.7714011816402624,0.8248909863515209,0.12509228777288814,0.30136820559300176,Upregulated
Feature0575,NA,C6 H11 N O7,209.05351,NA,NA,Feature0575,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,12361538.238522634,11453160.757197833,0.9265158215913617,-0.11011248232990571,0.46840416522152833,0.6061138177748706,Downregulated
Feature0574,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0574,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,11698433.863089656,16437199.1645612,1.4050768980643702,0.49064908946417346,0.13555877096801733,0.30398802261806607,Upregulated
Feature0573,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0573,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,13005959.940908534,9290205.955767017,0.7143037498174892,-0.4853903999489767,0.0029336787826345586,0.1302431386388236,Downregulated
Feature0572,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,329575.4710136077,586569.330401761,1.7797724102396637,0.831692767252779,0.17321938359803016,0.33188069332072495,Upregulated
Feature0571,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9177017.585242087,7835256.94699386,0.8537912098582046,-0.22804478538128778,0.45501203945932717,0.59294251831982,Downregulated
Feature0570,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1396814.6582985525,4418071.040415643,3.1629615383598964,1.6612760127775923,0.11477679204396231,0.29530270911052897,Upregulated
Feature0569,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,3409825.7365343566,9537971.79433058,2.7972021244770957,1.4839845060289467,0.055383932007238026,0.24513653722181605,Upregulated
Feature0568,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Phenol,6071963.725215826,15013428.290870134,2.4725820130515497,1.3060183745174347,0.0017911335461250487,0.1302431386388236,Upregulated
Feature0567,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,85967.6933367814,140145.1040109971,1.6302066342756671,0.7050548425856393,0.1966813409829835,0.3536481804213261,Upregulated
Feature0566,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0566,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Phenol,12638724.701915566,11956035.547717767,0.9459843322566929,-0.08011180557507677,0.3274514079955155,0.4759073572162803,Downregulated
Feature0565,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0565,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,60104.25716381443,82461.50487837773,1.3719744452315337,0.45625360973150547,0.06215648384102322,0.2524949108355725,Upregulated
Feature0564,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,74664.1303626766,77398.21522949176,1.0366184519063506,0.05188497917179445,0.889306758768341,0.923890910498221,Upregulated
Feature0563,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6299208.390535846,8520207.351095736,1.352583820515733,0.43571800159021884,0.1006602367416389,0.29205985495082226,Upregulated
Feature0562,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Phenol,1642713.2628817733,3518312.1565334233,2.1417688868971148,1.0988028107528036,0.02524306903640867,0.202913517900705,Upregulated
Feature0561,NA,C11 H23 N O11,345.1272,NA,NA,Feature0561,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,12875932.517771,14613238.683749033,1.1349266286989508,0.18259903246447817,0.33942886195260125,0.48514545619212557,Upregulated
Feature0560,NA,C10 H15 N O5,229.09493,NA,NA,Feature0560,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,2287781.829205407,1791741.6528790232,0.7831785487610642,-0.3525868447821393,0.23130003549644554,0.3810846399809279,Downregulated
Feature0559,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0559,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,6551432.641093473,5250679.01372716,0.8014550864482048,-0.31930642088808747,0.15201135331333113,0.31604977772306975,Downregulated
Feature0558,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1350247.6732824459,1505670.692855048,1.1151070449133005,0.15718220857868606,0.7348510478024071,0.814726161693973,Upregulated
Feature0557,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Phenol,204858.878200138,346059.9960827996,1.6892604270961322,0.7563917602986632,0.1344775972977802,0.30398802261806607,Upregulated
Feature0556,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,3321441.81111139,19677455.9521661,5.924371725055695,2.5666621654527955,0.08068376960723152,0.27515863069700236,Upregulated
Feature0555,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8608319.112382207,8384128.819973347,0.9739565541795047,-0.03807067624271738,0.9375126158547477,0.9586479233215527,Downregulated
Feature0554,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,10399558.715550587,10105636.6335764,0.9717370621183492,-0.04136210049572651,0.7481562762763513,0.82377953089506,Downregulated
Feature0553,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,11936949.591030186,11653703.667633634,0.9762714987412369,-0.03464568130152083,0.8769755801033017,0.9144671011857848,Downregulated
Feature0552,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,1121523.938771032,4275663.40772797,3.8123692771223854,1.930687869633554,0.02758547260462791,0.2077241628348491,Upregulated
Feature0551,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Phenol,2400472.907975043,5731046.867620003,2.38746575667647,1.2554800407809188,0.01409284158235365,0.18115825478491981,Upregulated
Feature0550,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,692644.1305706113,944575.8883347467,1.363724669920454,0.4475523999076154,0.22860729039287464,0.3780008505232887,Upregulated
Feature0549,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,4940632.233523197,4435051.79549779,0.8976688783684524,-0.15574471632464515,0.5302619588805625,0.6545147611265029,Downregulated
Feature0548,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0548,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,6421170.601666204,4271511.899199903,0.6652232379702706,-0.5880895283083318,0.053531447800014696,0.24513653722181605,Downregulated
Feature0547,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0547,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,6557086.26726705,11937018.466360467,1.8204760437498004,0.8643157560031015,0.019376104652902557,0.1914215549792269,Upregulated
Feature0546,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,10855419.90333594,11721486.757152334,1.079781976333338,0.11074004070743088,0.5454063589868748,0.6666077720950693,Upregulated
Feature0545,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0545,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,298609.0422806,569191.390326121,1.9061425132305854,0.9306559867425295,0.1238228091123427,0.30136820559300176,Upregulated
Feature0544,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,270219.7573410037,1515992.8290241,5.610222005754352,2.4880578617901525,0.017158551723515596,0.1914215549792269,Upregulated
Feature0543,NA,C11 H19 N O5,245.12631,NA,NA,Feature0543,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,224059.26639596434,641859.5005257643,2.864686253999648,1.5183771408722686,0.0023510884253043597,0.1302431386388236,Upregulated
Feature0542,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,2435858.590103703,2197037.3939317465,0.9019560506746046,-0.1488709574361323,0.5004887125124038,0.6285586775277445,Downregulated
Feature0541,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0541,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,272754.69049202633,559862.5589280037,2.052623028839794,1.0374686959508101,0.06503656794249595,0.2524949108355725,Upregulated
Feature0540,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0540,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,5094754.515995524,3621798.14177712,0.7108876650300028,-0.4923064927195775,0.007801485160739848,0.15915029727909288,Downregulated
Feature0539,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,1391211.2736032533,4005180.627774507,2.8789161673489336,1.5255257789288326,0.03491129542936987,0.22518500080187337,Upregulated
Feature0538,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,213899.92014167886,318267.24222244666,1.487925951592871,0.5733027307954407,0.38751691141946015,0.5251134959089786,Upregulated
Feature0537,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,1244050.0402509067,2280963.7393691433,1.8334983847668267,0.8745989950978933,0.10614588195883477,0.2923176437002599,Upregulated
Feature0536,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0536,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5252073.050894183,2925029.9460375197,0.5569286484961445,-0.8444355878867332,0.042519797228864446,0.2294308083870162,Downregulated
Feature0535,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,3553721.9928248003,6965016.853095493,1.9599217010104681,0.9707960197382974,0.05070150560258292,0.23924543223939654,Upregulated
Feature0534,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0534,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,11782817.919997633,11212158.845436066,0.9515685400185085,-0.07162051954040609,0.6181000599988573,0.7254270578647677,Downregulated
Feature0533,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,159844.72874109924,169812.44989094467,1.062358772968924,0.08727106611660823,0.9139086782688636,0.9398193131285933,Upregulated
Feature0532,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0532,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,545815.3889943734,184469.88989593866,0.33797121447200584,-1.565027719702298,0.1603655037966449,0.31789769480536323,Downregulated
Feature0531,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,6366127.266636596,4848363.04851895,0.7615875155258208,-0.3929182657118478,0.2691870715714754,0.41317085403993903,Downregulated
Feature0530,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,263259.091321997,238592.23926125665,0.9063019934587183,-0.14193623681353318,0.8482758383081919,0.8920013969838719,Downregulated
Feature0529,NA,C12 H19 N O9,321.10608,NA,NA,Feature0529,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,525756.540125486,18547396.484988533,35.277538308057366,5.140677986999717,0.0492123926399618,0.23924543223939654,Upregulated
Feature0528,NA,C6 H15 N O4,165.10013,NA,NA,Feature0528,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,7912218.18631192,6903915.515433803,0.8725638440276491,-0.1966674001354753,0.4226447107595062,0.5578910182025483,Downregulated
Feature0527,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1774399.88387588,1749964.5451992566,0.9862289561114892,-0.020005483272038375,0.9355022999391113,0.9585694799376099,Downregulated
Feature0526,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0526,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,5608325.273773484,7554934.049666896,1.347092702521454,0.4298491357787228,0.15878641727014725,0.31789769480536323,Upregulated
Feature0525,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Phenol,4143905.338695553,7154159.193425143,1.7264292035389925,0.7877911741580631,0.4997449004635621,0.6285586775277445,Upregulated
Feature0524,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0524,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,9651708.019158121,5411050.59731842,0.5606314018801414,-0.8348755405491105,0.42645363969037325,0.5613863416533115,Downregulated
Feature0523,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0523,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,9083533.39245301,9962317.992878087,1.0967447976968092,0.13322786308856377,0.36191490391232944,0.5025600522148931,Upregulated
Feature0522,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0522,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Phenol,74845.23976891796,119079.04458750736,1.5910035822606716,0.6699370840057852,0.09653894324477225,0.29061626158377885,Upregulated
Feature0521,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,260028.60555370332,906650.5919303054,3.486734046047315,1.801876325376032,0.05304894628614251,0.24393818743054055,Upregulated
Feature0520,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,8493476.626694597,8885760.600982158,1.0461865018918908,0.06514006130780839,0.8984581399360092,0.9299539049891166,Upregulated
Feature0519,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,10910470.869058633,8710640.766820753,0.7983744121918284,-0.3248626116815242,0.022285647217287232,0.202913517900705,Downregulated
Feature0518,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,2920989.41032695,1607374.24815965,0.5502841751075485,-0.8617512541759947,0.38404800136973666,0.5229391474961705,Downregulated
Feature0517,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,494556.287955654,908745.1191936784,1.8374958348020518,0.8777409796811192,0.12564916660116754,0.30136820559300176,Upregulated
Feature0516,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0516,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,5507846.8048586035,2201187.050427057,0.3996456561728146,-1.3232066865029466,0.0373433053558216,0.22796760781090802,Downregulated
Feature0515,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0515,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2396837.5299947034,3703071.4952908065,1.5449822730783882,0.6275902849331331,0.22348144491727304,0.3749957127248786,Upregulated
Feature0514,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0514,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Phenol,1599886.56334768,169892.913640365,0.10619059971656544,-3.235272034418908,0.008931321101988174,0.16545908274686147,Downregulated
Feature0513,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Phenol,1890101.3522957268,1621924.1140508133,0.8581148900194245,-0.22075727680724294,0.34078891698504793,0.48585154365593874,Downregulated
Feature0512,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4909553.463811837,9165861.90617624,1.866944106778247,0.9006787363049303,0.11083161740362311,0.29530270911052897,Upregulated
Feature0511,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,491404.36878685537,390847.899260364,0.7953691991490875,-0.33030340035205424,0.5961066632022028,0.7070102284491244,Downregulated
Feature0510,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,5645693.43595835,4216297.117391827,0.7468165186826363,-0.4211742562922373,0.40222242889929166,0.5398248387858914,Downregulated
Feature0509,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,175890.51113953366,265778.3200182606,1.5110441052014405,0.5955457713080017,0.15380696016069922,0.31604977772306975,Upregulated
Feature0508,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1166934.8641069406,5158140.828094747,4.42024742490001,2.144127127237885,0.005622912304362079,0.1493750767119406,Upregulated
Feature0507,NA,C33 H47 N O8,585.33043,NA,NA,Feature0507,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Phenol,134558.62041443755,248174.19628249333,1.8443574667912195,0.8831183008793274,0.09897103846450735,0.2909412949178688,Upregulated
Feature0506,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,4301509.4173783995,1929439.4746605698,0.4485494014881146,-1.1566612081664593,0.05669424780118214,0.2456021082352369,Downregulated
Feature0505,NA,C29 H28 O9,520.17351,NA,NA,Feature0505,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,685363.4884107823,1003071.378887899,1.4635611552839156,0.5494830303940702,0.4081150435160424,0.5444769070451838,Upregulated
Feature0504,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,2698067.7333210767,4368064.5648519695,1.6189603066322127,0.6950676143453159,0.008995547279463948,0.16545908274686147,Upregulated
Feature0503,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,7861724.54903757,5741983.80446087,0.7303720409746233,-0.4532965556321736,0.029308909006407913,0.20988072323333595,Downregulated
Feature0502,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,201254.47446364065,358153.9341617157,1.7796073111727064,0.8315589306722688,0.12956814889152513,0.30349783519058704,Upregulated
Feature0501,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,176842.277689002,324593.227962671,1.835495630369037,0.8761696799223829,0.11956899473674379,0.2984601699370005,Upregulated
Feature0500,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,8463904.266064154,8199264.903498776,0.9687331810183105,-0.04582873722304941,0.7029002642647284,0.7894435400450703,Downregulated
Feature0499,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0499,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,39517.87566819543,58503.488270560636,1.480431001954012,0.5660172527860294,0.03081036798238052,0.20988072323333595,Upregulated
Feature0498,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0498,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Phenol,162987.59735728067,299163.022826422,1.8354956308156067,0.8761696802733856,0.11956899482336,0.2984601699370005,Upregulated
Feature0497,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,1918994.4846711643,3596677.8742536632,1.8742512826293942,0.906314389443323,0.15616230315621113,0.31741685532838565,Upregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Phenol,303966.6820198697,992518.012550227,3.2652197469634126,1.7071800873877097,0.00752146869333614,0.15627940507265092,Upregulated
Feature0495,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,10481416.981842566,9011159.805642463,0.8597272507384167,-0.21804905881525535,0.08851909065304232,0.28184191679182835,Downregulated
Feature0494,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,299601.74457640667,1203209.7430470265,4.016030496578684,2.005770224740821,0.21344897674309746,0.3673155704076002,Upregulated
Feature0493,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Phenol,103927.76155816687,18752370.454251498,180.43658569280421,7.495348081838758,0.02084800476629752,0.20032723703957303,Upregulated
Feature0492,NA,C10 H23 N O6,253.1525,NA,NA,Feature0492,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1961608.9376341186,99244.33643750224,0.050593334141921305,-4.3049088727185785,0.18918231944920272,0.3475836870484041,Downregulated
Feature0491,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,576611.8322363817,404439.298066756,0.7014065190062841,-0.5116772555507973,0.7449404521657526,0.8218517082890604,Downregulated
Feature0490,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4760617.04014335,18025043.028072532,3.7862829284688204,1.9207822198762692,0.014369950691495423,0.18115825478491981,Upregulated
Feature0489,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0489,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,8025297.662252317,6156532.7147483295,0.7671407309545806,-0.3824368323792689,0.06083679565973308,0.2524949108355725,Downregulated
Feature0488,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0488,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,1587830.1192735333,3231874.656342507,2.0354032947940044,1.0253146783998686,0.018863159810913563,0.1914215549792269,Upregulated
Feature0487,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,176853.39313272532,324257.714450298,1.8334831393760613,0.8745869991554491,0.018101346981868667,0.1914215549792269,Upregulated
Feature0486,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,1883606.5964518567,2785321.6258770535,1.4787172815829772,0.5643462475370407,0.1441039128846231,0.3109319043395137,Upregulated
Feature0485,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,145965.43419812666,161690.57756588268,1.1077319671889678,0.14760884132730703,0.2346460243736006,0.3819254480242743,Upregulated
Feature0484,NA,C18 H29 N O12,451.16881,NA,NA,Feature0484,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,146066.14499468467,112498.15365385533,0.7701863676757481,-0.3767205072765469,0.1720680731905057,0.33139764286350143,Downregulated
Feature0483,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,419744.71935261664,962908.2228249994,2.2940329643934962,1.1978861224894524,0.15688131779739975,0.31780102913059516,Upregulated
Feature0482,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0482,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5084467.2575374795,5038302.868745424,0.9909205062293165,-0.013158768927438337,0.9714346414692534,0.9820642741738556,Downregulated
Feature0481,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Phenol,3277426.1950552133,989158.258863209,0.30180946877021747,-1.7282900261548226,0.2149449639452738,0.3693235061969329,Downregulated
Feature0480,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,556837.9830681073,566565.6914696103,1.0174695489483396,0.024985617844239093,0.9715609129527449,0.9820642741738556,Upregulated
Feature0479,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,10775765.884365793,10070661.871072954,0.934565763504954,-0.09763190780911724,0.5376120129078414,0.6599569786461685,Downregulated
Feature0478,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0478,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,186637.47337132934,198112.562527337,1.061483307444787,0.0860816840497157,0.82395304177455575,0.8746218664816003,Upregulated
Feature0477,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Phenol,4855506.10469708,7503801.706165407,1.545421124876445,0.6280000238801045,0.14081452579609444,0.3094889519155126,Upregulated
Feature0476,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1673299.7019721137,295892.255232357,0.17683159501171547,-2.4995520266379647,0.11472132666111796,0.29530270911052897,Downregulated
Feature0475,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2958369.28985073,2183287.5510265133,0.738003723374466,-0.43829999990206125,0.07260999872529264,0.2645078524992803,Downregulated
Feature0474,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0474,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,6650038.839824236,4658910.422343543,0.7005839416220132,-0.5133701749857513,0.010823364813088923,0.1733067798896166,Downregulated
Feature0473,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Phenol,8026357.25866399,3697394.5113038435,0.4606566082406461,-1.1182363858627797,0.12070091662750645,0.29895458820322796,Downregulated
Feature0472,NA,C19 H35 P S,326.21985,NA,NA,Feature0472,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,3204041.16929384,2378021.524955657,0.7421944348735584,-0.4301309114353509,0.6132868895680186,0.7212870965359716,Downregulated
Feature0471,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,5077344.46968108,2810671.0605131183,0.5535710797832992,-0.8531595206682622,0.5732679007485129,0.6922470084045355,Downregulated
Feature0470,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,5643104.736007187,9142350.643367117,1.620092319930224,0.6960760265114911,0.14845621230108907,0.31368398946706544,Upregulated
Feature0469,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,353214.8129669259,244430.92219162453,0.692017755819636,-0.5311190398226142,0.5510359175305315,0.670566485324573,Downregulated
Feature0468,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,563677.1994604319,541324.793200737,0.9603453780264816,-0.058374745766479635,0.7429674764615869,0.8204817997932092,Downregulated
Feature0467,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,9721686.267426167,7729544.757434133,0.7950827196854753,-0.3308231299975033,0.1955861108116141,0.35224336489667896,Downregulated
Feature0466,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1253384.5784716664,612960.6374067296,0.48904434276202163,-1.0319628113407575,0.11485252420977325,0.29530270911052897,Downregulated
Feature0465,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1673348.19833275,1428250.9258021966,0.8535288275478126,-0.22848821444286516,0.3373411238296962,0.48401117766869456,Downregulated
Feature0464,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0464,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,7479280.28526706,1695411.2041559666,0.2266810628150472,-2.141264223102813,0.2235065769435041,0.3749957127248786,Downregulated
Feature0463,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3122737.8249198734,5649195.62991176,1.8090521672458089,0.855234011243657,0.08096857703945962,0.2752931619341627,Upregulated
Feature0462,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0462,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,542839.7636084047,507772.21220166667,0.9353998108509326,-0.09634495786072991,0.8140580007293926,0.8698791207794081,Downregulated
Feature0461,NA,C29 H28 O9,520.17353,NA,NA,Feature0461,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,146689.72480960272,266679.424440735,1.8179829895166415,0.8623387006019891,0.10287997161475933,0.29205985495082226,Upregulated
Feature0460,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,108768.4869734146,123861.45134102867,1.1387622903249828,0.18746662469272182,0.30189709417381205,0.4468714243575424,Upregulated
Feature0459,NA,C14 H29 N O2,243.2198,NA,NA,Feature0459,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,1650489.6858632895,226365.325560423,0.1371504029981396,-2.8661692335282716,0.3548189914442143,0.49639265386584597,Downregulated
Feature0458,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0458,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,278476.916701044,503734.454553764,1.8088912378132327,0.855105666453001,0.12676738275567828,0.30136820559300176,Upregulated
Feature0457,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,5231804.973110854,4246383.53543562,0.8116479030201124,-0.30107408019924875,0.3492217737860994,0.49308461903443046,Downregulated
Feature0456,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,9708852.2645758,10551218.621417966,1.0867627124078987,0.12003697164136395,0.2560936709556909,0.40187006826893035,Upregulated
Feature0455,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0455,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,9818673.753141271,9593587.637990704,0.977075710955509,-0.03345773782362984,0.7935114113590085,0.8595908313223575,Downregulated
Feature0454,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3285217.60382081,2685608.2597337565,0.8174826095569167,-0.2907400546409916,0.4873322452978947,0.6192375755653883,Downregulated
Feature0453,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,8470480.94020404,3467968.6543359966,0.4094181521471506,-1.2883530271324741,0.019135360263339563,0.1914215549792269,Downregulated
Feature0452,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,115893.39039873297,154444.42045609068,1.332642180237564,0.4142894630264292,0.19277526757674932,0.35055729371331074,Upregulated
Feature0451,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,3768027.0972151533,2285580.2357926234,0.6065721335926256,-0.72124887396317,0.036153299378654136,0.22788765113960638,Downregulated
Feature0450,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,377961.23666151334,299702.900052661,0.7929461304018928,-0.33470523657713686,0.22036294839180595,0.3734253838098514,Downregulated
Feature0449,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,6928330.7856964795,4393979.61852388,0.6342046525254307,-0.6569796337957424,0.14155752415859818,0.3094889519155126,Downregulated
Feature0448,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Phenol,3433886.742378313,2755622.7419348266,0.8024792163140126,-0.3174640670249969,0.2325952417276564,0.38153780879887494,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1518090.7244955266,2613602.2453635065,1.7216377145259396,0.783781587307578,0.04659193574162592,0.23233845289824126,Upregulated
Feature0446,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0446,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,5652638.399947284,4342406.89143313,0.7682088582693751,-0.38042949510636165,0.7614737322214584,0.8343491480004652,Downregulated
Feature0445,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0445,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,6321186.46198739,4015121.8621024867,0.6351848480103411,-0.654751596702877,0.34448783053239873,0.48740901116942165,Downregulated
Feature0444,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,102201.06187416603,182061.24645026834,1.7814026890878034,0.8330136769571219,0.1285616795799923,0.30288690529752293,Upregulated
Feature0443,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0443,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2012029.1801506067,1351404.6071754266,0.6716625288079916,-0.5741915498387504,0.05053928189925718,0.23924543223939654,Downregulated
Feature0442,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,153157.48429534296,2311492.9976614453,15.092262766630794,3.915737218675389,0.11155676726442418,0.29530270911052897,Upregulated
Feature0441,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,2166961.8628233066,3173160.346519917,1.4643360369922003,0.5502466624142568,0.2871130812526954,0.4306696218790431,Upregulated
Feature0440,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,318839.25969845965,205561.96629140468,0.6447197452591431,-0.6332559265839613,0.2956672982903814,0.4405313193173094,Downregulated
Feature0439,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1824762.04941803,1990210.7552655668,1.090668646851957,0.12521286687473893,0.6426452092439763,0.7471999220432554,Upregulated
Feature0438,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3490583.17412986,4622207.252864877,1.3241934147628813,0.40511386092137275,0.2831486409114098,0.42704574162928155,Upregulated
Feature0437,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Phenol,442874.555185057,115927.8938333798,0.2617623714799755,-1.9336703710988903,0.001558809590082116,0.1302431386388236,Downregulated
Feature0436,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,5748634.18869586,6141513.82807685,1.0683431275125403,0.09537508228417242,0.18076360993431034,0.337317507574313,Upregulated
Feature0435,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,561369.1894856766,379723.8693299257,0.6764244929042625,-0.5639991951161583,0.2480232270587914,0.3969786886732724,Downregulated
Feature0434,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0434,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,285437.2866776957,359687.6247885383,1.260128376972288,0.3335707173654989,0.23177550461633337,0.38130808823977425,Upregulated
Feature0433,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0433,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,270951.36733339867,213014.369606938,0.7861719676979129,-0.3470831719600191,0.5643838620050974,0.6838430811768026,Downregulated
Feature0432,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0432,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,5025577.483352207,4031427.1147983135,0.8021818643037285,-0.31799874475941337,0.28187151677704964,0.4262262019189349,Downregulated
Feature0431,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0431,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,127609.83589699194,136379.299542696,1.068720906849084,0.09588514690768919,0.6932009540610664,0.7832542502079722,Upregulated
Feature0430,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,145270.3541977877,173170.74725525331,1.1920584086927937,0.2534549269636365,0.368964134282183,0.5073256846380017,Upregulated
Feature0429,NA,C7 H15 N O6,209.08992,NA,NA,Feature0429,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2144145.924749793,191313.77032247334,0.08922609609455491,-3.4863904706596784,0.09756531190342632,0.2909412949178688,Downregulated
Feature0428,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0428,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,63121.0101593427,84715.79370307687,1.3421172045444185,0.4245106648552463,0.14242910005099177,0.30950277076313015,Upregulated
Feature0427,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,6459122.87642545,4102414.6304904665,0.6351349415357134,-0.654864953708071,0.24943940797138248,0.39710778173245215,Downregulated
Feature0426,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Phenol,1088685.1367457933,2240833.49081765,2.058293454355189,1.041448684351213,0.1551066928418062,0.31653801046110563,Upregulated
Feature0425,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0425,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,91858.44420093454,144353.27678767766,1.5714753068527265,0.6521196027373605,0.15436299304121412,0.31604977772306975,Upregulated
Feature0424,NA,C16 H25 N O9,375.15307,NA,NA,Feature0424,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,255665.52351066965,224427.18433438067,0.8778155977100865,-0.18801018953479745,0.46479242766579765,0.6028868252497398,Downregulated
Feature0423,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,819473.6828158466,1843531.18832107,2.2496527063399925,1.1697023003252622,0.0215384565305177,0.20138456856034048,Upregulated
Feature0422,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Phenol,723229.609393311,1376447.7480833265,1.903196066928143,0.9284241954606334,0.19083025955598656,0.3475836870484041,Upregulated
Feature0421,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0421,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,127278.45703487027,169883.46295074697,1.33473854812841,0.4165571709322032,0.4914726593024736,0.622384112570401,Upregulated
Feature0420,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0420,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2477718.843356143,2566399.5765513866,1.0357912817400714,0.05073332046178346,0.8717839744749866,0.9109699054696848,Upregulated
Feature0419,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,817420.4554110516,1024613.0488821137,1.2534712608419767,0.32592891893526077,0.8182805244704069,0.8726107574967877,Upregulated
Feature0418,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0418,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,170497.970211232,308093.150495288,1.8070194625401563,0.8536120448626985,0.1132196094514701,0.29530270911052897,Upregulated
Feature0417,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0417,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5996040.11259655,7399905.264698473,1.2341320481083284,0.30349676641517964,0.07482474729996792,0.26632745741913066,Upregulated
Feature0416,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,110860.1679948662,107521.8713921392,0.9698873214509147,-0.04411094575926931,0.8708042030687688,0.9109699054696848,Downregulated
Feature0415,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1724936.0307892533,1258293.188580005,0.7294723781752455,-0.45507474405612414,0.16850822807415466,0.3276711124769524,Downregulated
Feature0414,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,999870.8205950904,3629511.0852260836,3.629980003882819,1.859961601009304,0.028960916077917124,0.20988072323333595,Upregulated
Feature0413,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0413,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,104909.29108748354,102447.67739395656,0.9765357894614478,-0.034255175882954694,0.9146904544887915,0.9398193131285933,Downregulated
Feature0412,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0412,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,104766.02819529513,103213.50082263324,0.9851810038100537,-0.021539284725323054,0.9589527692448134,0.9728255037004347,Downregulated
Feature0411,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,787988.3219784843,444812.930078729,0.5644917794744608,-0.8249755232739988,0.219591975182331,0.3733063578099627,Downregulated
Feature0410,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0410,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,4099839.73693005,844379.3793296987,0.20595424053379413,-2.279604263732937,0.18949225552383278,0.3475836870484041,Downregulated
Feature0409,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,589143.1331430944,284267.805906955,0.4825105987239105,-1.0513674622299856,0.15335004667398322,0.31604977772306975,Downregulated
Feature0408,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0408,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,2941129.3677087394,5171749.406646143,1.7584229593665062,0.8142821284948437,0.7077680355209695,0.7933224134410867,Upregulated
Feature0407,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0407,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,785469.737303838,961435.6166245807,1.224026300395422,0.29163455724821524,0.40394197585970165,0.541484942550281,Upregulated
Feature0406,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,4705980.250155074,11557996.7505575,2.4560232164545606,1.2963241983732197,0.08672116200247562,0.28184191679182835,Upregulated
Feature0405,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0405,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,1099504.32948552,2060021.5125091532,1.8735910876067932,0.9058061182830726,0.09235589698043901,0.28625225528191317,Upregulated
Feature0404,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1013431.1569293056,1103197.5338803118,1.088576689533602,0.12244304805205361,0.9089707892512879,0.9365153586225391,Upregulated
Feature0403,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Phenol,144410.36833003056,233424.57652233765,1.6163976258884476,0.6927821376526448,0.08722198417106951,0.28184191679182835,Upregulated
Feature0402,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,1506497.2563150222,3337263.9091821765,2.2152472533174827,1.1474677331943792,0.09429991863526199,0.289527806056069,Upregulated
Feature0401,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0401,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,4794005.392953407,504462.09449164104,0.10522768606667354,-3.2484137581652988,0.13618774349211293,0.30398802261806607,Downregulated
Feature0400,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0400,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,4531041.54984468,445257.737059625,0.09826829707065653,-3.3471301347145,0.19482766119215705,0.3514415367485534,Downregulated
Feature0399,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,6507683.52688069,5351529.786380723,0.82234020205126,-0.28219273470950257,0.3765913586563589,0.5152872005029692,Downregulated
Feature0398,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,5884337.157569326,4425873.429637977,0.752144771980774,-0.41091771793566184,0.29400748406326516,0.4392495301184867,Downregulated
Feature0397,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0397,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,6878915.081698104,5881112.72873852,0.854947714703687,-0.22609190184112138,0.74007380300611,0.8185590556721009,Downregulated
Feature0396,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,4391870.857388597,232000.339589721,0.05282494570609215,-4.242636810427417,0.14390626760803876,0.3109319043395137,Downregulated
Feature0395,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0395,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1804279.41989807,3868788.9558554664,2.144229387748616,1.1004592522812675,8.453475042400988e-4,0.1302431386388236,Upregulated
Feature0394,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0394,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Phenol,75397.8563274629,124551.2030780036,1.6519196850512725,0.7241435458403225,0.09069653143266077,0.2828485191409447,Upregulated
Feature0393,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0393,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8642697.781166019,6494804.471472244,0.7514788363450104,-0.412195620326611,0.046422509433431534,0.23233845289824126,Downregulated
Feature0392,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2114476.902739187,2127595.65768495,1.0062042554963684,0.008923196277023706,0.9845021485820518,0.9897951708862563,Upregulated
Feature0391,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0391,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4775681.652696704,7126009.443266213,1.4921449881908146,0.5773877256609042,0.12903738033174328,0.30288690529752293,Upregulated
Feature0390,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1724426.7963486498,311115.729723157,0.1804168958531161,-2.4705936430895585,0.10770149045564792,0.2923176437002599,Downregulated
Feature0389,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1764659.1056601333,2025076.38496355,1.1475737033108149,0.19858681419363788,0.4994628160729685,0.6285586775277445,Upregulated
Feature0388,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0388,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,892035.3231210996,2158280.6908535035,2.41950137501506,1.2747097591059473,0.14877859370264665,0.31368398946706544,Upregulated
Feature0387,NA,C10 H21 N O10,315.11663,NA,NA,Feature0387,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4407883.5256380765,9108738.25042309,2.0664652769164373,1.0471651221245835,0.036996826276517854,0.22796760781090802,Upregulated
Feature0386,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0386,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,3745050.84004458,3237317.577312337,0.8644255353483534,-0.21018640448505527,0.6535421950548248,0.7567330679582183,Downregulated
Feature0385,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0385,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,1280997.4780926933,724495.7018284204,0.5655715286084237,-0.822218599508981,0.10362378762002988,0.29231724387699126,Downregulated
Feature0384,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,1257826.8265141067,1895056.84478895,1.5066118839592872,0.5913078142796007,0.0234610308064118,0.202913517900705,Upregulated
Feature0383,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,5987453.581593187,2538750.53106978,0.4240117266001835,-1.2378239299243936,0.10203340822816118,0.29205985495082226,Downregulated
Feature0382,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,191134.16094799433,259652.580847091,1.3584833792099564,0.44199691456389334,0.3535335630948244,0.4956585203055909,Upregulated
Feature0381,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,6880024.239859833,7861569.55875749,1.142665968124213,0.1924037267712271,0.5902211993416807,0.7022568246674081,Upregulated
Feature0380,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Phenol,8429388.42041347,7689778.80351773,0.9122582113899715,-0.13248586307785304,0.6475376997175757,0.7513312296619648,Downregulated
Feature0379,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Phenol,5208828.83693448,3473590.8113816935,0.6668659923611513,-0.5845312159061207,0.10893863957949297,0.29382008078892097,Downregulated
Feature0378,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Phenol,3414505.0617016465,3639011.30242574,1.0657507418109402,0.09187005948349831,0.5760629339642657,0.6922470084045355,Upregulated
Feature0377,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1752501.177375543,326912.7723481757,0.18654068628800793,-2.422437764652471,0.24100327898321428,0.38851390663673335,Downregulated
Feature0376,NA,C13 H17 N O5,267.11069,NA,NA,Feature0376,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Phenol,4699759.4460987765,3510655.466848367,0.7469862036795366,-0.42084649721009143,0.26214745877922163,0.407381507964386,Downregulated
Feature0375,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0375,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Phenol,231355.63272933065,412680.3060835673,1.783748686881436,0.8349123676517956,0.0278272831962604,0.2081480783080278,Upregulated
Feature0374,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Phenol,4076380.96721636,6830988.7718755,1.6757483725914313,0.7448055327672937,0.07440159211245337,0.26632745741913066,Upregulated
Feature0373,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,370896.324264279,2286550.295970951,6.164931131379155,2.624084778330836,0.21005280983580318,0.36370255036384436,Upregulated
Feature0372,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0372,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,532735.3405007087,150036.37120265633,0.2816339743138493,-1.8281067139746352,0.14472671675457835,0.311044188694344,Downregulated
Feature0371,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,7266901.4185193395,8454622.266838543,1.1634425431026705,0.21839996465159958,0.1809175297930898,0.337317507574313,Upregulated
Feature0370,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,8884262.047400687,5826336.367618893,0.6558042003413816,-0.608662952850998,0.17536599286195936,0.3323659526877,Downregulated
Feature0369,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,634479.2366289264,1473444.2540131833,2.3222891608585825,1.2155476211972376,0.028612748377420467,0.20988072323333595,Upregulated
Feature0368,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1956645.5294857032,2925090.5032804166,1.4949516707041288,0.580098845251134,0.016894498604319404,0.1914215549792269,Upregulated
Feature0367,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0367,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,2153138.435743601,231681.57630416166,0.10760180230777816,-3.216225851948984,0.11769358779285645,0.2969014535049403,Downregulated
Feature0366,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,3879025.80406628,165062.34380201832,0.04255252533483738,-4.554611436713393,0.12534766269795364,0.30136820559300176,Downregulated
Feature0365,NA,C20 H31 N O14,509.17464,NA,NA,Feature0365,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,8254923.030264667,10138442.1081887,1.2281691871648672,0.29650931369742023,0.4599855725358793,0.5980345450582347,Upregulated
Feature0364,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0364,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,124412.82469717889,219890.72612274266,1.767428130162282,0.8216515511780629,0.14178490324162812,0.3094889519155126,Upregulated
Feature0363,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0363,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,4155614.12247135,3843085.454234367,0.9247936263988049,-0.11279663994942243,0.6726557471944202,0.7677718701445977,Downregulated
Feature0362,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0362,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,82172.98055802593,101094.52152774743,1.2302647517618055,0.298968815525972,0.33353373972262484,0.4810088122992096,Upregulated
Feature0361,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0361,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,842195.5622514903,1186306.3755492168,1.4085877778526819,0.49424946980224604,0.03080292342051702,0.20988072323333595,Upregulated
Feature0360,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Phenol,7396339.85572627,10732874.9388157,1.4511062428406767,0.5371531502855535,0.11920710853015876,0.2984601699370005,Upregulated
Feature0359,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Phenol,1617090.2575549968,2169164.46281949,1.3413997472838757,0.4237392353654553,0.03738506224350007,0.22796760781090802,Upregulated
Feature0358,NA,C16 H33 N O2,271.25118,NA,NA,Feature0358,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,4564451.377474864,415272.9679899117,0.09097982071607653,-3.4583095981027543,0.36485349521624455,0.5060143654296988,Downregulated
Feature0357,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0357,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,168210.779732954,313852.756377484,1.8658302213196236,0.8998177160911568,0.11533785213788299,0.29530270911052897,Upregulated
Feature0356,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,700644.3010114203,2073966.0464624367,2.9600840875584766,1.5656381592935913,0.03512243773647758,0.22518500080187337,Upregulated
Feature0355,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,1496492.7736539466,931609.342138893,0.6225284602372033,-0.6837883002696947,0.004060819557686602,0.1302431386388236,Downregulated
Feature0354,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,259494.76766930366,436019.07582163,1.6802615318135676,0.7486858051973951,0.07605671203698838,0.26632745741913066,Upregulated
Feature0353,NA,C25 H34 O2,366.25594,NA,NA,Feature0353,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,360201.44468169764,624386.4006211017,1.7334366917180433,0.7936351476383764,0.12324412359269397,0.30136820559300176,Upregulated
Feature0352,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3281134.0241894135,3526992.29824929,1.0749308843367391,0.10424390071685478,0.5138538272651451,0.6391901881882869,Upregulated
Feature0351,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0351,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,5503148.91915246,6258683.561505667,1.1372913314636535,0.18560186603349668,0.5978455124453813,0.708105280603935,Upregulated
Feature0350,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,598049.0082573036,1474301.5235813532,2.465185132364691,1.3016959952908742,0.04054973183823775,0.2294308083870162,Upregulated
Feature0349,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0349,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,86402.14918981993,132934.5090842257,1.5385555837526352,0.6215765651896474,0.14901147178868968,0.31368398946706544,Upregulated
Feature0348,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0348,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,7428427.057799127,4349385.682629693,0.5855056055323665,-0.7722451119746474,0.004989157449125723,0.14353422199792465,Downregulated
Feature0347,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0347,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,4997622.914013526,7268475.2742414335,1.4543864951996177,0.5404107084682301,0.07619927952639557,0.26632745741913066,Upregulated
Feature0346,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0346,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1051301.5875547715,2173758.3162478735,2.0676829008732223,1.0480149514095392,0.06994785119321655,0.25816279289075317,Upregulated
Feature0345,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0345,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,105312.39300054264,278362.28996751,2.6432054389465414,1.4022885605190312,0.012456769216348255,0.1733067798896166,Upregulated
Feature0344,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,357526.42592422635,288625.8975280173,0.8072854944411528,-0.30884912575176204,0.6302102775784995,0.7373263101596208,Downregulated
Feature0343,NA,C6 H9 O P S,160.01125,NA,NA,Feature0343,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,2508435.6796545857,235577.53489600867,0.09391412217850767,-3.412514072737315,0.2535106488976441,0.4005880550661267,Downregulated
Feature0342,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,193731.37647997434,417518.5020883797,2.155141359518177,1.1077825013270703,0.0032378545455538595,0.1302431386388236,Upregulated
Feature0341,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0341,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,82323.27072426496,74113.226216669,0.9002706715201486,-0.15156927372121815,0.47592237296218876,0.6104270799409673,Downregulated
Feature0340,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Phenol,157305.62647279262,283057.001188013,1.7994079902600952,0.8475223343331117,0.4506317570987557,0.5899752992588144,Upregulated
Feature0339,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3943388.5065538534,3028572.3537394167,0.7680126745579275,-0.38079797486412986,0.47074580259858034,0.606402744564417,Downregulated
Feature0338,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1079335.712286582,1672786.0953398934,1.5498292850850655,0.6321093102574623,0.33780718491756817,0.48406087034164946,Upregulated
Feature0337,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Phenol,177730.47773169866,329008.771451006,1.8511668659760008,0.8884349469997473,0.1455420669024337,0.311044188694344,Upregulated
Feature0336,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,2997902.415036887,1212755.9305877169,0.40453482558497317,-1.3056641881875393,0.022883615016152624,0.202913517900705,Downregulated
Feature0335,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Phenol,737476.6437047997,426319.41549972334,0.578078531895001,-0.7906625989098676,0.4726438253378814,0.6081495092076868,Downregulated
Feature0334,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,3972947.1803183733,1489922.54514485,0.3750169527865343,-1.4149722802168598,0.0029697083813648834,0.1302431386388236,Downregulated
Feature0333,NA,C28 H40,376.313,NA,NA,Feature0333,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,750043.8661213659,2148833.998610503,2.864944432813742,1.5185071573830589,0.003180778212838183,0.1302431386388236,Upregulated
Feature0332,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0332,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1033142.634640396,2649964.829137067,2.5649554478597576,1.3589337670759938,0.045982024184632285,0.23233845289824126,Upregulated
Feature0331,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,6159828.726237137,3404521.2699771733,0.5526973916459683,-0.8554382908540253,0.025769086141365388,0.2036120750043096,Downregulated
Feature0330,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,93634.33271700867,94646.62871131237,1.0108111625824596,0.015513501442651364,0.9571772589253745,0.9727834098861143,Upregulated
Feature0329,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1865481.5234918934,2286203.6599991266,1.225530047448396,0.2934058565208445,0.36891251538956965,0.5073256846380017,Upregulated
Feature0328,NA,C11 H21 N O12,359.10644,NA,NA,Feature0328,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,2095120.9533763267,12058849.989511468,5.755682014481505,2.5249868893674954,0.012179217799034718,0.1733067798896166,Upregulated
Feature0327,NA,C17 H33 N O15,491.18523,NA,NA,Feature0327,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,6416242.20511605,4868255.88863763,0.7587394198984385,-0.39832360077304774,0.018008848566377852,0.1914215549792269,Downregulated
Feature0326,NA,C8 H19 N O4,193.13145,NA,NA,Feature0326,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,1836574.5667863253,114480.4696000016,0.062333689941226726,-4.003844071886499,0.18952907956678383,0.3475836870484041,Downregulated
Feature0325,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0325,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,673439.3571701413,1196110.95517006,1.776122738350542,0.8287312820772046,0.17403874983132833,0.33188069332072495,Upregulated
Feature0324,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,3356690.1597186686,324654.74694662367,0.09671871143860167,-3.3700611657576087,0.1997146665528651,0.35539505387094084,Downregulated
Feature0323,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0323,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,655966.844450812,2317129.5465457668,3.5323882085621445,1.8206439035160287,0.010880222215841935,0.1733067798896166,Upregulated
Feature0322,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0322,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Phenol,6446528.46764552,5307973.031661247,0.8233847191246314,-0.28036142039344814,0.35385247305238704,0.4956585203055909,Downregulated
Feature0321,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2264493.17554906,2988091.89085231,1.3195411331402236,0.40003632349668206,0.015657844444023523,0.18890431684079992,Upregulated
Feature0320,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,1960888.7651494402,722829.7614644357,0.3686235416874086,-1.4397798850388184,0.1359851367152595,0.30398802261806607,Downregulated
Feature0319,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,6213067.645839304,5916061.294237574,0.9521965044432398,-0.07066876218262996,0.5010705515719135,0.6285586775277445,Downregulated
Feature0318,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Phenol,123615.33629907084,264334.30426823103,2.1383617290714594,1.0965059225603995,0.022098364444567923,0.202913517900705,Upregulated
Feature0317,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,202637.611008148,299716.93601464265,1.4790785112571778,0.5646986344485668,0.015051316634022776,0.1855777721249841,Upregulated
Feature0316,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0316,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,565664.512093837,989443.950178631,1.749170982135952,0.8066713201474637,0.3202352896302281,0.46679726866154747,Upregulated
Feature0315,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0315,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,526253.2525124854,813332.4104516763,1.5455152183261422,0.6280878601460301,0.04080797078609359,0.2294308083870162,Upregulated
Feature0314,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,1025352.264860328,871631.6876731423,0.8500802285660086,-0.23432908905789385,0.4499116635410217,0.5899752992588144,Downregulated
Feature0313,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,528397.4591517963,658203.6926033257,1.2456602150583753,0.31691059091235985,0.6096379900735591,0.718455770923203,Upregulated
Feature0312,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0312,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,774806.8515744103,114968.97337443114,0.14838404325002258,-2.7525921374421545,0.15381199358755518,0.31604977772306975,Downregulated
Feature0311,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0311,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,2012152.2850399048,341392.351251522,0.1696652652931543,-2.559236855395757,0.3250625055685329,0.4730481598545965,Downregulated
Feature0310,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,250850.70003442367,422190.34720236366,1.6830343592600197,0.7510646296851221,0.010755745601299119,0.1733067798896166,Upregulated
Feature0309,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,250726.23422737568,934780.5446252926,3.728291726256175,1.8985147504312339,0.0391105579094999,0.2294308083870162,Upregulated
Feature0308,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Phenol,170268.11029108067,315372.24440232903,1.852209693660114,0.8892474392450859,0.1453664299063555,0.311044188694344,Upregulated
Feature0307,NA,C7 H16 O6,196.09463,NA,NA,Feature0307,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,422190.27220287966,452717.081006356,1.0723058080997352,0.10071640291543034,0.7020956863357246,0.7894435400450703,Upregulated
Feature0306,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,76161.32733040793,125649.78422484436,1.6497845905408455,0.7222776666250577,0.12058646047389453,0.29895458820322796,Upregulated
Feature0305,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,1789893.9399690933,1055758.699804819,0.5898442786073956,-0.7615939677580655,0.1230178293017348,0.30136820559300176,Downregulated
Feature0304,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0304,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,395909.7765801,194435.03059264933,0.49110944486441965,-1.0258835266240782,0.098384732154183,0.2909412949178688,Downregulated
Feature0303,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,3332154.95319974,1417564.9039720334,0.42541986308613905,-1.2330406997954808,0.2015220943971466,0.35539505387094084,Downregulated
Feature0302,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0302,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6291209.6227821,6868364.249739493,1.0917398499753317,0.12662911828709472,0.14056432712223002,0.3094889519155126,Upregulated
Feature0301,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0301,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,105292.71798693883,176302.325089299,1.674401881345381,0.7436458377084852,0.01783867160513752,0.1914215549792269,Upregulated
Feature0300,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,1589713.10991937,1209375.3322806624,0.7607506818271139,-0.3945043731232977,0.24994793394199621,0.3972260366613594,Downregulated
Feature0299,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,814728.761896786,1265244.8383908956,1.5529644926800599,0.635024844007241,0.26090356070701687,0.4071401879183212,Upregulated
Feature0298,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0298,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Phenol,7050414.138926746,8359853.11626204,1.1857251150830446,0.24576959076783905,0.2958946216547524,0.4405313193173094,Upregulated
Feature0297,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,826836.8628371593,2654611.2224525833,3.210562254498072,1.6828259735918096,0.04512503732424278,0.23105372564185667,Upregulated
Feature0296,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,568339.3433536077,1119645.4613822286,1.9700298324862071,0.9782174768156779,0.05654868954144951,0.2456021082352369,Upregulated
Feature0295,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,102953.2381940693,180724.58339871166,1.7554045561737603,0.8118035569830635,0.1348233776587015,0.30398802261806607,Upregulated
Feature0294,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,5286325.068503137,3938666.52778997,0.7450670317754851,-0.4245578678901073,0.211048500929387,0.363742577638667,Downregulated
Feature0293,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Phenol,487573.3534719033,1181488.33898575,2.4232012077211147,1.2769142022839013,0.04412101436325413,0.23105372564185667,Upregulated
Feature0292,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3053319.7334756833,3340946.8196720234,1.0942014303457588,0.12987834673276868,0.6704595140931657,0.766826299418194,Upregulated
Feature0291,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0291,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,171362.771979607,284020.38769966934,1.6574217633073136,0.7289407711809993,0.21712991736023715,0.37043217676559315,Upregulated
Feature0290,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Phenol,4556931.751015847,875751.5184625377,0.19218008219397015,-2.379469273911064,0.1537177810128386,0.31604977772306975,Downregulated
Feature0289,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Phenol,1619609.30764591,568080.0107548919,0.3507512633281862,-1.511479794765561,0.1326483544394669,0.30398802261806607,Downregulated
Feature0288,NA,C8 H19 N O7,241.11608,NA,NA,Feature0288,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,510540.3849592857,235222.12033463334,0.4607316624979466,-1.1180013483471452,0.2366017070326656,0.3830694304338395,Downregulated
Feature0287,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,644975.5384150697,1318883.9098748583,2.044858806763148,1.0320012315215767,0.062039972474108855,0.2524949108355725,Upregulated
Feature0286,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0286,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,2663727.3992910935,2591269.9338484267,0.9727984682434283,-0.039787137754044036,0.8912114566801977,0.9250131863045161,Downregulated
Feature0285,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,237094.83120873355,130209.996740337,0.5491895208196366,-0.864623997453658,0.39141964604409346,0.5291239070620155,Downregulated
Feature0284,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,3693112.9977902602,1538660.6824066266,0.4166297330537327,-1.2631622929584105,0.003757852155333913,0.1302431386388236,Downregulated
Feature0283,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Phenol,2836920.12565454,2169327.6100921934,0.7646770138061895,-0.38707758757245775,0.5982921622215065,0.708105280603935,Downregulated
Feature0282,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Phenol,7172753.99677277,4972366.142445443,0.6932297057284629,-0.5285946178432555,0.06816483776666438,0.2566969667571648,Downregulated
Feature0281,NA,C31 H37 N O11,599.23689,NA,NA,Feature0281,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Phenol,168866.77259980867,312776.6730924593,1.8522096933403092,0.8892474389959883,0.1453664299572106,0.311044188694344,Upregulated
Feature0280,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0280,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,124672.37834995372,201412.28490910624,1.615532546782292,0.692009815665749,0.5063531673282231,0.6340717117659223,Upregulated
Feature0279,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0279,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,971773.7872852724,1754072.48349326,1.8050214015274084,0.8520159427603224,0.07101816619087524,0.2612537130038099,Upregulated
Feature0278,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,542006.2333020524,682350.584956544,1.2589349402856032,0.33220372884518945,0.5954358747271464,0.70696195919985,Upregulated
Feature0277,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0277,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,1126087.5930729522,310107.701295608,0.27538506169787635,-1.8604777924911458,0.061413444223374684,0.2524949108355725,Downregulated
Feature0276,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1265677.661432221,1266129.6020432333,1.0003570740203322,5.150569671042311e-4,0.9989726232572496,0.9989726232572496,Upregulated
Feature0275,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,575281.0960507314,1532872.5886153867,2.6645627661650293,1.4138988174734375,0.042608176707270524,0.2294308083870162,Upregulated
Feature0274,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,2658227.2584713465,2646559.52728604,0.9956107096757348,-0.006346345571858154,0.9815640395483562,0.9877263249984356,Downregulated
Feature0273,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0273,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Phenol,4124026.6026954,3036087.32609814,0.7361948936298811,-0.4418403519032265,0.09857988371719154,0.2909412949178688,Downregulated
Feature0272,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Phenol,1227971.1473371033,2339984.98762845,1.9055700068383417,0.9302226108597317,0.010224269183694342,0.1712183585687321,Upregulated
Feature0271,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,87072.6396807853,163793.9790472269,1.8811187951543409,0.9115909598490582,0.3858409025666914,0.5241083446487018,Upregulated
Feature0270,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0270,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,199103.111052055,345970.501986227,1.7376448823834496,0.7971332727322201,0.19460700642357473,0.3514415367485534,Upregulated
Feature0269,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Phenol,341301.80240054964,618199.4213180244,1.8112984372479506,0.8570242704546938,0.16375787394969069,0.32121736813208557,Upregulated
Feature0268,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0268,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1303549.4186364,1437555.2205601244,1.1028007070601922,0.14117209744433384,0.8259144089670508,0.875048127347527,Upregulated
Feature0267,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,479195.16049507365,618352.6166701423,1.2903982920681003,0.3678164341002164,0.1581288904100128,0.31789769480536323,Upregulated
Feature0266,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,6014571.100083251,5283365.782731603,0.8784276874968646,-0.18700456697309883,0.3329397633537198,0.4810088122992096,Downregulated
Feature0265,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,5066233.69003474,3628722.43451983,0.7162564256870961,-0.4814519182390068,0.05542784600758688,0.24513653722181605,Downregulated
Feature0264,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1968641.4456926694,1065701.10865232,0.5413383483234305,-0.885397502924982,0.28598441257079726,0.4295508847448923,Downregulated
Feature0263,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0263,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,113299.84526447963,171276.89564011866,1.511713411790645,0.5961846616638653,0.12580883957748754,0.30136820559300176,Upregulated
Feature0262,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4818204.365344574,4180748.59439058,0.8676984779767833,-0.2047342963421015,0.7104483854718987,0.7939472993022613,Downregulated
Feature0261,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,156472.56142368176,275205.5943896353,1.7588105664382865,0.8146001049945171,0.3058170722657473,0.4502975788479901,Upregulated
Feature0260,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2653979.0238414602,4937938.48898898,1.8605793205711318,0.8957518970238908,0.030978539406479686,0.20988072323333595,Upregulated
Feature0259,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,87755.8046773801,98992.78198844877,1.1280482510801375,0.17382877882290265,0.8086954925386458,0.8674534824362912,Upregulated
Feature0258,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Phenol,2176220.5798323466,2990179.1452991934,1.3740239261635663,0.4584071263226702,0.25338197022940717,0.4005880550661267,Upregulated
Feature0257,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Phenol,5409207.5649380665,3200708.4293366433,0.5917148474913978,-0.7570259987964554,0.014627021508535806,0.1823502014730797,Downregulated
Feature0256,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,288777.1706745307,259545.499683749,0.8987743008822274,-0.15396922150419629,0.828475884750509,0.8761073917908305,Downregulated
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1881887.5769353868,3206761.912046117,1.7040135401011889,0.7689367992722187,0.12439871591429297,0.30136820559300176,Upregulated
Feature0254,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3710696.935693307,1995439.4170953534,0.5377532716027442,-0.8949836980922159,0.026850956400079267,0.20533948787435963,Downregulated
Feature0253,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1867190.67893936,2087315.7052938966,1.1178910267908881,0.1607795595846141,0.6953895690320718,0.7849367167545116,Upregulated
Feature0252,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,5257045.8125884,4713920.8469739435,0.896686278762513,-0.15732477333257197,0.3042460959005085,0.44916331526364545,Downregulated
Feature0251,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Phenol,2202370.0298784566,2509500.3770426135,1.139454470864329,0.1883432800481328,0.5013903889370155,0.6285586775277445,Upregulated
Feature0250,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Phenol,2361454.2239150833,3872302.5998252933,1.6397957498432285,0.7135161264047298,0.058496425460106014,0.2524345744855344,Upregulated
Feature0249,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,269612.75446185365,160891.63694942344,0.5967508372167434,-0.7447994095374172,0.2462219762143034,0.3946586533034977,Downregulated
Feature0248,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,4893070.848986637,4730817.16521131,0.9668401114999325,-0.048650767148353743,0.5776892394502601,0.693227087340312,Downregulated
Feature0247,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,69111.83597244926,101028.11270394419,1.4618062345242577,0.5477520917163189,0.09680923279694213,0.29061626158377885,Upregulated
Feature0246,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,2807182.8075733334,697273.666575538,0.24838911975892855,-2.00932611462051,0.09372579962853313,0.28890205270113783,Downregulated
Feature0245,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0245,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,1573595.5993091266,1526143.2433048033,0.9698446309679838,-0.044174448706623196,0.7820872872052995,0.8519436274216953,Downregulated
Feature0244,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Phenol,1423324.053218596,8128954.251767887,5.711246313434873,2.513805606185583,0.05905108110611462,0.2524949108355725,Upregulated
Feature0243,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,441198.17126031534,1705592.6262678166,3.865819800194694,1.9507743898966556,0.010197781919948913,0.1712183585687321,Upregulated
Feature0242,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Phenol,986921.9595555214,1728100.6315641333,1.7510002840978587,0.8081793178471638,0.1029877939162216,0.29205985495082226,Upregulated
Feature0241,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,233873.2218865147,243885.30314110333,1.0428098658488014,0.06047613714587855,0.887231905705156,0.923445452876795,Upregulated
Feature0240,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,826045.735486224,561527.0610011093,0.6797772046732804,-0.5568661108486297,0.13684819266433118,0.30398802261806607,Downregulated
Feature0239,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,1760075.5789240394,334725.507893724,0.19017678098706803,-2.394586979076056,0.08917458151613107,0.28184191679182835,Downregulated
Feature0238,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0238,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1094952.0914864487,2387684.986996277,2.1806296417543556,1.124744763387314,0.023968534554464488,0.202913517900705,Upregulated
Feature0237,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,889960.3576131014,997125.6582648742,1.1204158137326399,0.16403425110329126,0.6052131575891854,0.7140369745689442,Upregulated
Feature0236,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4076584.10113168,8137904.107808757,1.996255665509178,0.9972965021088419,0.07516288530245807,0.26632745741913066,Upregulated
Feature0235,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,1277709.5069391236,445822.85581495997,0.3489234864370475,-1.5190173846412498,0.22862042404569316,0.3780008505232887,Downregulated
Feature0234,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,538607.3977437296,690397.207987014,1.281819022314109,0.35819258485767963,0.25774343603643024,0.4038940436213334,Upregulated
Feature0233,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,88399.68900091623,142981.50739903134,1.6174435568155605,0.6937153680304047,0.08895232948065468,0.28184191679182835,Upregulated
Feature0232,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0232,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1939358.64634459,1634194.2512463368,0.8426467452663056,-0.24700014422185188,0.5762288848024156,0.6922470084045355,Downregulated
Feature0231,NA,C9 H15 N O5,217.09502,NA,NA,Feature0231,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,319699.702192894,8870881.116244657,27.747542632655698,4.794288104596507,0.0413502167505948,0.2294308083870162,Upregulated
Feature0230,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Phenol,1572575.7949790333,3732882.7894799635,2.373737915462277,1.2471606557314772,0.0073720075784648,0.1560640094912737,Upregulated
Feature0229,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,2555668.734735267,840405.8348727893,0.32883989362566746,-1.604542762885303,0.0035280691429651536,0.1302431386388236,Downregulated
Feature0228,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,177883.665338103,253697.71624162034,1.4262001840327372,0.5121764952753391,0.22021418741170398,0.3734253838098514,Upregulated
Feature0227,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,1629153.9465030986,395420.5535677473,0.24271527832989553,-2.0426631694349253,0.17456351560655964,0.33188069332072495,Downregulated
Feature0226,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0226,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4288815.7895054,3840446.5467379033,0.895456166743127,-0.15930528196151494,0.2668390776282068,0.4112547322786374,Downregulated
Feature0225,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,146319.59145147007,188000.21632557787,1.2848601780570994,0.36161137000350224,0.7322973058130029,0.8128291348049507,Upregulated
Feature0224,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Phenol,4462475.001911427,2943963.15703274,0.6597153274296758,-0.6000844708738815,0.09920162722821449,0.2909412949178688,Downregulated
Feature0223,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0223,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,92926.6074543551,116925.07145771067,1.25825180387806,0.33142066613925825,0.1049848668903017,0.29231724387699126,Upregulated
Feature0222,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,412806.9333521393,1292516.8164953701,3.131044350441678,1.6466439440272402,0.03546452712282767,0.22608636040802638,Upregulated
Feature0221,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,207436.81723470666,203291.96729251734,0.9800187353554525,-0.029118764898257585,0.9658257291906089,0.9780293033861581,Downregulated
Feature0220,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Phenol,151974.10583316983,99810.14137601867,0.6567575497735492,-0.6065672148946459,0.4052576626664741,0.5419536323144029,Downregulated
Feature0219,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,1700523.95368064,1870898.3453858832,1.100189351250526,0.13775184429619997,0.5119824724066172,0.638979492706354,Upregulated
Feature0218,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,342741.9855831017,697910.469805055,2.036256131905493,1.0259190432351766,0.4050837069730784,0.5419536323144029,Upregulated
Feature0217,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0217,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,4132230.5003930735,3670662.277024637,0.8883004654932656,-0.17088034763965093,0.08370030489363153,0.27949923241266245,Downregulated
Feature0216,NA,C19 H41 N O,299.31886,NA,NA,Feature0216,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,2151644.4788210066,278574.75724229036,0.1294706258326354,-2.9493032770725143,2.0224185771532927e-5,0.022691536435659944,Downregulated
Feature0215,NA,C16 H35 N O,257.27187,NA,NA,Feature0215,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,4016782.1016340987,6560241.311270253,1.6332081614786695,0.7077086821389533,0.544242095522202,0.6659101757643519,Upregulated
Feature0214,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0214,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,127959.74366763256,146392.29182754765,1.144049586468323,0.19414958411069552,0.6551156609855956,0.7573524656708119,Upregulated
Feature0213,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,2232376.4468029365,2766988.0338661633,1.239480929763823,0.3097360747753335,0.4379222075715031,0.5753497855916,Upregulated
Feature0212,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,105503.10608488474,126990.17419897276,1.2036628959227054,0.2674314000067139,0.4014508821523331,0.5394345985328356,Upregulated
Feature0211,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,135159.32667407434,123577.96473620093,0.914313261075938,-0.1292395502054717,0.7768038743915473,0.8470106385493839,Downregulated
Feature0210,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0210,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,100113.91518426784,126373.33949614866,1.26229544877501,0.3360496223618134,0.06949180325794056,0.25816279289075317,Upregulated
Feature0209,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0209,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,689533.3242165013,558198.6794702751,0.8095311130967334,-0.30484156550494823,0.6701196558471734,0.766826299418194,Downregulated
Feature0208,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,353203.55045307166,496387.4919601433,1.4053864728239638,0.490966917461423,0.4699813025527072,0.6061138177748706,Upregulated
Feature0207,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,854212.5735198354,394362.33121179196,0.46166767317273,-1.1150733791476528,0.21643544238654572,0.37043217676559315,Downregulated
Feature0206,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Phenol,121347.01880396494,200858.81157651934,1.655243067001135,0.7270430876115858,0.13231418567629577,0.30398802261806607,Upregulated
Feature0205,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0205,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,110627.07339107667,141651.94521625634,1.280445562502625,0.3566459187870394,0.0625853101898873,0.2524949108355725,Upregulated
Feature0204,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,1814501.089458727,223068.25373191267,0.1229364121233208,-3.0240158088806335,0.41945311925223305,0.5543302706725625,Downregulated
Feature0203,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1862289.8951603868,3194445.6651836433,1.715332115308786,0.7784879319207483,0.0011175014946821888,0.1302431386388236,Upregulated
Feature0202,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,288037.58412831766,239960.04357192834,0.8330858776576487,-0.26346287314432343,0.6631472290021097,0.7631430008335496,Downregulated
Feature0201,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0201,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,2328946.405090473,2981043.02240162,1.2799964034749074,0.3561397565563651,0.05593133113082434,0.24513653722181605,Upregulated
Feature0200,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0200,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Phenol,2439527.3982307566,1058676.6037370432,0.4339679089092576,-1.204339732791893,0.2993582948172182,0.443698820059338,Downregulated
Feature0199,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,2980198.2402525763,4524106.743836563,1.518055638960829,0.6022246686070307,0.49826437454567313,0.6285586775277445,Upregulated
Feature0198,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,209698.87035509024,538914.4717291964,2.569944562966096,1.361737238953585,0.39612619853914544,0.5341990321645688,Upregulated
Feature0197,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0197,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,4954246.081334863,5233168.616284886,1.0562996933076991,0.07901921415428721,0.681295397869494,0.7736978101311459,Upregulated
Feature0196,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,184554.871172703,191664.84825172668,1.0385250036146176,0.054535951046851716,0.869446571928387,0.9108487896392626,Upregulated
Feature0195,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,278599.8573050823,397930.84993779496,1.428323954602886,0.5143232305531449,0.22616206162914212,0.3776098707557998,Upregulated
Feature0194,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,2031367.0723145732,3151759.06025543,1.551545805389207,0.6337062893464112,0.02627759362059182,0.2042456212056748,Upregulated
Feature0193,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Phenol,1022615.7045186233,2482093.9027818465,2.4272010412261804,1.2792936095882914,0.011676640461878315,0.1733067798896166,Upregulated
Feature0192,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Phenol,239208.30047965332,191142.35950487235,0.7990624034433563,-0.3236199188646199,0.33176390744823125,0.4803085214927942,Downregulated
Feature0191,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,3239508.5193082,1715913.7663319833,0.5296833628017185,-0.9167979001663649,0.01848373643245989,0.1914215549792269,Downregulated
Feature0190,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5355037.14947899,4852469.023060284,0.9061503940327281,-0.14217758024643892,0.2909975270035283,0.43591351842184084,Downregulated
Feature0189,NA,C14 H21 N O10,363.11672,NA,NA,Feature0189,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,69406.30283277243,107558.49576992757,1.5496934915129976,0.6319828980790384,0.13719085073319348,0.30398802261806607,Upregulated
Feature0188,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0188,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,179018.66774305367,423830.3742310343,2.3675205472948777,1.2433769466447853,0.027198560614164643,0.2061944933046806,Upregulated
Feature0187,NA,C19 H37 N O2,311.28246,NA,NA,Feature0187,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,2976415.979744726,225244.10841319733,0.07567628649558437,-3.724014893722287,0.3599275575485234,0.5005663310240236,Downregulated
Feature0186,NA,C13 H25 N O9,339.15309,NA,NA,Feature0186,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,81663.5169810122,138282.70808929202,1.6933229574406463,0.7598571561415685,0.08222163363475275,0.27545152412041163,Upregulated
Feature0185,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0185,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,2627861.0210694834,1724097.9828196666,0.6560841570373442,-0.6080472112129414,0.2068905988476113,0.3617622357374913,Downregulated
Feature0184,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0184,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Phenol,3377758.289366577,2791726.198372937,0.8265026562621397,-0.2749086387453834,0.4994827648749012,0.6285586775277445,Downregulated
Feature0183,NA,C9 H21 N O7,255.13179,NA,NA,Feature0183,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,166852.47797317166,184827.823675747,1.107731967309863,0.14760884148475914,0.23464602364865159,0.3819254480242743,Upregulated
Feature0182,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0182,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,2177143.0810249834,2398904.88828596,1.1018590873488079,0.13993973481490168,0.554557582771261,0.6733913505079597,Upregulated
Feature0181,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,354017.7132497333,344644.3352875697,0.9735228560285304,-0.03871324445547196,0.9519372510959895,0.9683350822572078,Downregulated
Feature0180,NA,C17 H31 N O9,393.19997,NA,NA,Feature0180,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,803363.1321210493,1860075.5900327873,2.315360906744367,1.2112370910180636,0.5797831723177136,0.6949134064774887,Upregulated
Feature0179,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,704937.0227090303,723558.6436932663,1.0264160065145596,0.03761557392206973,0.9416306027773798,0.9595908595061036,Upregulated
Feature0178,NA,C10 H23 N O6,253.15257,NA,NA,Feature0178,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,208606.4165918182,8596242.737391876,41.2079497737225,5.364850781634547,0.01699160251584254,0.1914215549792269,Upregulated
Feature0177,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Phenol,907775.5199186109,1777146.0755111168,1.957693324524164,0.9691547823876195,0.17570855199501212,0.33245361777133825,Upregulated
Feature0176,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,162099.14794199166,297694.70451865,1.8364976515803908,0.8769570512258513,0.07476685016093639,0.26632745741913066,Upregulated
Feature0175,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1333485.4993645267,1232147.6748515533,0.9240053044736775,-0.11402696108596157,0.2087401245187417,0.362548637322025,Downregulated
Feature0174,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0174,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4129206.2148598568,3420985.3666522866,0.8284849892798084,-0.27145253635163474,0.20127249343197157,0.35539505387094084,Downregulated
Feature0173,NA,C20 H33 N O11,463.2054,NA,NA,Feature0173,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,78427.4999812049,134489.55683786867,1.71482651965317,0.7780626336019476,0.09872282849466112,0.2909412949178688,Upregulated
Feature0172,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,134654.91866755165,174346.433223557,1.294764684043955,0.37268992029711845,0.1597381242763886,0.31789769480536323,Upregulated
Feature0171,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0171,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,71547.088549571,79758.16900789256,1.114764704263718,0.15673922959434777,0.4504314295041791,0.5899752992588144,Upregulated
Feature0170,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,2858935.4534904,1220351.8891770367,0.4268553484434707,-1.228180838716275,0.040137521986009755,0.2294308083870162,Downregulated
Feature0169,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1103446.225362564,1474504.0640575667,1.3362717911995057,0.41821347483004884,0.1691783612078654,0.32840505410938575,Upregulated
Feature0168,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,53418.3206392855,84980.01589170413,1.5908402749225923,0.6697889920832587,0.15982017902283102,0.31789769480536323,Upregulated
Feature0167,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0167,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,893270.40741559,342409.55986331403,0.3833212843734221,-1.3833739871547464,0.19858910230752802,0.35539505387094084,Downregulated
Feature0166,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0166,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1686699.3319397133,1215153.995521057,0.7204330804611295,-0.47306366722243604,0.13461295808301443,0.30398802261806607,Downregulated
Feature0165,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,360811.14223298465,567037.0361913224,1.5715618777237554,0.6521990770540903,0.10266887559695753,0.29205985495082226,Upregulated
Feature0164,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0164,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Phenol,83979.34044139613,297900.64925936743,3.5473087510999624,1.8267249052083614,0.1778636872623304,0.3347041673945071,Upregulated
Feature0163,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0163,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1993611.55188236,1623026.7398315233,0.8141138319042484,-0.29669756422628785,0.79932002404573,0.8615149538706139,Downregulated
Feature0162,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0162,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1039420.0653410123,1469171.2400735468,1.4134528368870212,0.49922374512566153,0.2616599940484315,0.407381507964386,Upregulated
Feature0161,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,578198.0473955794,254053.401755289,0.4393882042660654,-1.1864319549288023,0.28549570102725,0.4293916575771776,Downregulated
Feature0160,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0160,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Phenol,120210.39751280927,218931.75586799067,1.8212380991807462,0.8649195450782486,0.1373635717177892,0.30398802261806607,Upregulated
Feature0159,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Phenol,1404868.85409018,2111461.869767533,1.5029601258652405,0.5878067344841064,0.04431757500556778,0.23105372564185667,Upregulated
Feature0158,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,67578.9544065766,98464.32872414924,1.4570265194065648,0.5430271362000615,0.0907535355532443,0.2828485191409447,Upregulated
Feature0157,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,903124.9999058163,2835850.3003521035,3.1400418553886165,1.6507837897408322,0.00568896763358234,0.1493750767119406,Upregulated
Feature0156,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,2149988.631257573,7980690.21045857,3.711968563196773,1.8921844922779398,0.004062843005667403,0.1302431386388236,Upregulated
Feature0155,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0155,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,436282.94623267034,816951.4887866046,1.8725267532023202,0.9049863309332088,0.08453701947601484,0.2798572806491105,Upregulated
Feature0154,NA,C9 H9 O P S,196.01126,NA,NA,Feature0154,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,124699.00108029896,205278.117411674,1.6461889480532947,0.7191299364732732,0.1577211235937233,0.31789769480536323,Upregulated
Feature0153,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,139166.7073104232,123116.94957169067,0.8846724331636864,-0.17678472616654642,0.845643007356806,0.8909027739477335,Downregulated
Feature0152,NA,C8 H11 N O7,233.05354,NA,NA,Feature0152,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,1176411.7044207894,2071495.52525304,1.7608593296621002,0.8162796607278864,0.11464186687419754,0.29530270911052897,Upregulated
Feature0151,NA,C23 H32,308.25044,NA,NA,Feature0151,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,364094.928104267,483403.20591637737,1.3276845366490349,0.4089123970789417,0.4802356943759533,0.614395038870946,Upregulated
Feature0150,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0150,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3786767.27394052,5050813.38790158,1.3338061260484304,0.41554898037907967,0.02509770762205196,0.202913517900705,Upregulated
Feature0149,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0149,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,40531.3431425271,61381.5742017497,1.514422406035336,0.5987676611337445,0.10811522234565356,0.2923176437002599,Upregulated
Feature0148,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0148,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Phenol,1728289.2806014833,1217137.3527622533,0.7042439980526074,-0.505852731660443,0.3556502757987781,0.4969360018010324,Downregulated
Feature0147,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,2309583.66870215,4565102.541585053,1.976591107500501,0.9830144551878115,0.12188300793615826,0.30121747776292856,Upregulated
Feature0146,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0146,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,677060.7595947568,920742.8489874953,1.3599117005962513,0.44351297997008865,0.19401870493372014,0.3514415367485534,Upregulated
Feature0145,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0145,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,110161.9202833763,75226.37521608063,0.6828709505296494,-0.5503151322166866,0.5460904868239729,0.6667176563835665,Downregulated
Feature0144,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Phenol,610941.2454146267,697008.3424336923,1.1408762260938115,0.19014228182226534,0.48501284172685233,0.6169891251899414,Upregulated
Feature0143,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,3596334.129489727,2944763.2574823103,0.8188235996581702,-0.288375411408353,0.315796991430328,0.4625642615989923,Downregulated
Feature0142,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Phenol,3351092.0659034066,1494826.5297384167,0.44607145979304297,-1.164653249246672,0.006841574764066632,0.15125995219337665,Downregulated
Feature0141,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Phenol,4175650.600352453,3678038.5831772964,0.8808300634317549,-0.18306438481372514,0.14261402182222666,0.30950277076313015,Downregulated
Feature0140,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0140,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,466913.925640039,207574.22332136365,0.4445663577860177,-1.1695293172189773,0.08800966849300433,0.28184191679182835,Downregulated
Feature0139,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,385171.990961938,1038556.9983699777,2.6963461070371704,1.4310056949090872,0.0012822605523150536,0.1302431386388236,Upregulated
Feature0138,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,1896855.6014650166,1896123.64522811,0.9996141212666155,-5.56812773052652e-4,0.9979104558559846,0.9988006525159809,Downregulated
Feature0137,NA,C9 H19 N O8,269.11107,NA,NA,Feature0137,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,1516261.1864592184,287178.01138186,0.18939877505700697,-2.4005010947299352,0.20166147860225397,0.35539505387094084,Downregulated
Feature0136,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,67969.46753576084,106061.03621634307,1.5604217608522692,0.6419360227104043,0.13561415227930573,0.30398802261806607,Upregulated
Feature0135,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,4371737.864185894,3353083.25468997,0.7669909218846501,-0.3827185928169156,0.12826855503083287,0.30288690529752293,Downregulated
Feature0134,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1102841.9739153148,1477357.8942875534,1.3395916452496186,0.42179328340082395,0.0693147832097574,0.25816279289075317,Upregulated
Feature0133,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,468735.60500182497,743762.0115637596,1.586741019088712,0.666066677028857,0.22323739882262797,0.3749957127248786,Upregulated
Feature0132,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,109949.92909087184,195744.24105987066,1.7803034770317243,0.8321231892197427,0.09638986750714416,0.29061626158377885,Upregulated
Feature0131,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0131,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,393526.02164240467,362676.8156820494,0.9216082183546485,-0.11777451295237307,0.8184307564639551,0.8726107574967877,Downregulated
Feature0130,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,238877.28837700668,384030.5342801183,1.6076477462102816,0.6849513303557057,0.5005656292937158,0.6285586775277445,Upregulated
Feature0129,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,3618790.4522591066,1115158.2412521876,0.30815772727487617,-1.6982591267197689,0.011859218736408841,0.1733067798896166,Downregulated
Feature0128,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,1904700.6443001232,2693444.066667713,1.4141036150367932,0.4998878340249895,0.024129377270085992,0.202913517900705,Upregulated
Feature0127,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0127,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,384026.00364028104,195258.347241407,0.5084508480949285,-0.9758197792845814,0.320351066728513,0.46679726866154747,Downregulated
Feature0126,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,3229096.9641933106,150082.83687454302,0.046478268859305234,-4.427299854995412,0.16559174661677267,0.32424771327053914,Downregulated
Feature0125,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Phenol,249790.28984010735,280717.92902883433,1.1238144173199207,0.1684038137458899,0.7055870351920515,0.7916686534854818,Upregulated
Feature0124,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3030426.3581366865,1108998.006577521,0.3659544484886968,-1.4502640120318435,0.0018372799437624625,0.1302431386388236,Downregulated
Feature0123,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0123,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,161494.913851433,211963.0925032,1.3125063040573224,0.3923243521581088,0.06316897587288138,0.2524949108355725,Upregulated
Feature0122,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,213081.384669788,486777.08478603966,2.2844655601445316,1.1918566931118164,0.012122695012832661,0.1733067798896166,Upregulated
Feature0121,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,580393.8955104966,798881.103818977,1.3764464271566912,0.46094845971230364,0.21861741185163014,0.37221356008729745,Upregulated
Feature0120,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0120,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Phenol,459462.6239685038,584822.5248229794,1.2728402579772604,0.3480513717256979,0.7088099571880158,0.7936973772105327,Upregulated
Feature0119,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0119,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Phenol,1991769.20903301,1925694.6547994732,0.9668261995747913,-0.04867152633032413,0.7672904822018758,0.8399023619809802,Downregulated
Feature0118,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,72286.51369902426,106237.5053894466,1.4696725565128563,0.5554947579754366,0.12719402016889347,0.30136820559300176,Upregulated
Feature0117,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,640356.3810100884,932487.6348491446,1.4562010506996945,0.5422095552778549,0.49979249595517217,0.6285586775277445,Upregulated
Feature0116,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,163748.81188679504,129141.29952406434,0.7886548796051356,-0.3425339890835576,0.555632456229744,0.6739671523132679,Downregulated
Feature0115,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0115,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3516043.6922580334,4559826.444982576,1.2968628504312518,0.3750259156228286,0.006875452372426211,0.15125995219337665,Upregulated
Feature0114,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Phenol,219594.46201656034,279757.3229107853,1.273972578095744,0.34933422432023115,0.2974682823510453,0.441480704759091,Upregulated
Feature0113,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,113764.53901035526,237254.700139989,2.0854890478516617,1.0603857357938689,0.23523691291247914,0.3819254480242743,Upregulated
Feature0112,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,4147423.255634873,2739773.96765885,0.6605966641905843,-0.598158410410537,0.04291926848631614,0.2294308083870162,Downregulated
Feature0111,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,4049638.9916023565,1791477.9676978567,0.4423796717220482,-1.1766430026682932,0.0176141870573777,0.1914215549792269,Downregulated
Feature0110,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,2747842.986550097,907492.095749391,0.3302561682713694,-1.598342587612349,0.09499512108043427,0.29042105136852114,Downregulated
Feature0109,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0109,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Phenol,155110.286751328,169099.22114533934,1.0901870191010499,0.1245756472825098,0.5881975824134105,0.7013365435365,Upregulated
Feature0108,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,4436544.937103163,8939167.88851434,2.014894025699007,1.010703961522941,0.07580030194462956,0.26632745741913066,Upregulated
Feature0107,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157745.32925704034,203763.13371536534,1.2917221364021538,0.3692957638804497,0.26678261816797705,0.4112547322786374,Upregulated
Feature0106,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,1198222.312014181,2192207.33998104,1.8295497571698491,0.8714886523241946,0.16032536081006693,0.31789769480536323,Upregulated
Feature0105,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,61104.18638425867,74054.04661854511,1.2119308185015374,0.2773073467866076,0.37861666225368495,0.5167979258499203,Upregulated
Feature0104,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0104,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1299115.4129163234,1963829.8333385799,1.5116669495361232,0.5961403199958107,0.04502724625102105,0.23105372564185667,Upregulated
Feature0103,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0103,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,660310.933041641,844601.9446581353,1.2790973197544684,0.35512603543594234,0.15609604587525333,0.31741685532838565,Upregulated
Feature0102,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,2352000.321741776,521492.70308024203,0.22172305771372094,-2.173169286254096,0.15815641924443397,0.31789769480536323,Downregulated
Feature0101,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0101,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,425540.22743010835,559254.78858314,1.3142230805311896,0.39421018422924725,0.5803332102222878,0.6949134064774887,Upregulated
Feature0100,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0100,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Phenol,91188.492343987,147713.690416739,1.6198720542447842,0.6958798661986899,0.1591517908225509,0.31789769480536323,Upregulated
Feature0099,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1945243.1662082865,2993457.2220845334,1.538860166217394,0.6218621422117889,0.06481568813109247,0.2524949108355725,Upregulated
Feature0098,NA,C9 H19 N O8,269.11113,NA,NA,Feature0098,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,376875.0047136382,473558.30769657734,1.2565394408589188,0.32945595592890764,0.7324155572975091,0.8128291348049507,Upregulated
Feature0097,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,467327.75147804996,583643.5984688887,1.2488956554002164,0.3206529455406345,0.3679131532423926,0.5073256846380017,Upregulated
Feature0096,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,1950210.4303669266,1066907.375445897,0.5470729511200293,-0.8701948684479733,0.019003954682381703,0.1914215549792269,Downregulated
Feature0095,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0095,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,159278.63001107232,215833.69245289802,1.355069995503441,0.43836737523786345,0.37427812026509893,0.5138441515947502,Upregulated
Feature0094,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,1336537.0748539174,94452.98674525104,0.07066993390780027,-3.8227596300141307,0.1777438304911995,0.3347041673945071,Downregulated
Feature0093,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,618876.1888075847,686622.8808282961,1.1094672783440607,0.14986711857873422,0.4547655915610932,0.59294251831982,Upregulated
Feature0092,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,2649364.654610587,2664629.471841437,1.005761689771276,0.008288506223091314,0.9778159577908581,0.9866092667637973,Upregulated
Feature0091,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0091,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,601679.420898906,1225837.9825691932,2.037360660827983,1.0267013939171983,0.10428468587100603,0.29231724387699126,Upregulated
Feature0090,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,162736.21781201533,347277.5137379427,2.133990321313109,1.0935536328515387,0.1490138737842655,0.31368398946706544,Upregulated
Feature0089,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0089,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,867201.610052247,994727.3273533114,1.1470542902859477,0.19793367598558081,0.7098142285377835,0.7939472993022613,Upregulated
Feature0088,NA,C14 H27 N O10,369.16362,NA,NA,Feature0088,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1825661.5169103867,93336.2209920475,0.05112460339855482,-4.289838443449581,0.00213575488821721,0.1302431386388236,Downregulated
Feature0087,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0087,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,249583.99064567467,140205.23128273,0.5617557076478286,-0.831985217087191,0.22359370036804257,0.3749957127248786,Downregulated
Feature0086,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Phenol,123004.5837524213,224193.07202166767,1.8226399796036423,0.8660296184616533,0.11412860409278516,0.29530270911052897,Upregulated
Feature0085,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1778280.7305897034,1155050.7121484801,0.649532265788793,-0.622526900950503,0.1017452088270489,0.29205985495082226,Downregulated
Feature0084,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0084,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,4322708.98830849,3051468.871809333,0.7059158689753475,-0.5024318414822978,0.03989976225935893,0.2294308083870162,Downregulated
Feature0083,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0083,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2016746.06000934,2648700.588480597,1.313353545596281,0.39325533193547063,0.227513207464859,0.3780008505232887,Upregulated
Feature0082,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Phenol,2097990.251011743,2239249.47772976,1.0673307355217192,0.09400729571406255,0.8277413343001994,0.8761073917908305,Upregulated
Feature0081,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Phenol,284586.02225683467,240995.1431585707,0.8468270551287869,-0.23986073239518227,0.6010754700565171,0.7103581801374698,Downregulated
Feature0080,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,148818.68025339633,178528.586146069,1.1996382835950772,0.2625994682258132,0.6905943745987921,0.7810956535280694,Upregulated
Feature0079,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0079,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,304085.84350340464,332702.218641785,1.094106239240499,0.12975283263117288,0.7925292397166239,0.8595908313223575,Upregulated
Feature0078,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0078,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,606088.380457633,1345700.0960472834,2.2203034069572483,1.1507568359463327,0.05583326278994864,0.24513653722181605,Upregulated
Feature0077,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Phenol,4196079.998231627,622561.3827937254,0.14836737694612454,-2.7527541881847797,0.006364937870139622,0.1493750767119406,Downregulated
Feature0076,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0076,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,2943645.879598563,589353.9494388697,0.2002122447959815,-2.3203978841189246,1.7194308436096643e-4,0.09646007032650217,Downregulated
Feature0075,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,212704.16493327112,119212.42072031654,0.5604611492102916,-0.8353137250400158,0.38855525432562804,0.5258853984962059,Downregulated
Feature0074,NA,C10 H15 N O5,229.09499,NA,NA,Feature0074,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,179558.49032032865,364371.05262209696,2.029261061240081,1.0209544774794181,0.06366090411972522,0.2524949108355725,Upregulated
Feature0073,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0073,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,131011.49099736006,273700.0605048007,2.0891301856133815,1.0629023977600665,0.20043716847563217,0.35539505387094084,Upregulated
Feature0072,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0072,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,439549.92812079773,843739.9348209907,1.9195542550267757,0.9407713376539358,0.26385340471509217,0.4079465848703739,Upregulated
Feature0071,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,254180.66503266568,444342.1519363064,1.7481351379704761,0.8058167153556366,0.09656990807357868,0.29061626158377885,Upregulated
Feature0070,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,3537821.6043932335,3442262.622657187,0.9729893159063242,-0.03950413158045107,0.9142610066961818,0.9398193131285933,Downregulated
Feature0069,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0069,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,1741787.5139304532,3246473.42510413,1.8638745536637005,0.8983047640171329,0.052848457158412174,0.24393818743054055,Upregulated
Feature0068,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Phenol,3285904.92256315,2379454.96058067,0.7241399299906068,-0.46565958984771205,0.0331444983961259,0.2187536894144309,Downregulated
Feature0067,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0067,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,369796.98744327936,472687.92927520064,1.2782362899797908,0.3541545521471014,0.6102391708465351,0.718455770923203,Upregulated
Feature0066,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0066,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,372799.4728006227,743497.011743501,1.9943617574296608,0.9959271240353373,0.09931418534183935,0.2909412949178688,Upregulated
Feature0065,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,791401.0765918894,449714.19372467534,0.5682506721640265,-0.815400609329265,0.41832754751255663,0.5535319612191564,Downregulated
Feature0064,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,254739.1543490304,610171.0471167939,2.3952778232150727,1.260193000816961,0.2079181388633795,0.3618105232088343,Upregulated
Feature0063,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0063,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,366854.6910166356,683690.0441153747,1.8636535414627466,0.898133683773857,0.20099117208314965,0.35539505387094084,Upregulated
Feature0062,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0062,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,413358.0972828087,295764.7036911753,0.7155168983875522,-0.48294225535395763,0.4266695897230864,0.5613863416533115,Downregulated
Feature0061,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,181710.22737401834,230923.308271777,1.270832751733133,0.3457741765884186,0.4678996145182421,0.6061138177748706,Upregulated
Feature0060,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,81928.76652026213,111422.81855483401,1.3599962905248622,0.4436027164398176,0.24233910404184347,0.3901068504088212,Upregulated
Feature0059,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0059,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,3048872.743335103,3214287.366913757,1.054254354807118,0.07622298096791885,0.6772777281037852,0.7714777775963928,Upregulated
Feature0058,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0058,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,475316.316679178,727925.5414121296,1.53145498243742,0.6149029591217612,0.04996939274020149,0.23924543223939654,Upregulated
Feature0057,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0057,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Phenol,2930336.5734404633,84118.28664099057,0.028706015344247156,-5.122503104512032,0.011681000900110847,0.1733067798896166,Downregulated
Feature0056,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Phenol,172680.74134565,315549.0941121827,1.8273554517614519,0.8697572900219391,0.06420176519863842,0.2524949108355725,Upregulated
Feature0055,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Phenol,367524.44341187866,1225795.4749378543,3.3352760528205883,1.7378061747691755,0.26857339945282976,0.4127936358713356,Upregulated
Feature0054,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1709552.7511866868,2260694.9447821532,1.3223896970788944,0.40314738954996576,0.14205598060293137,0.3094889519155126,Upregulated
Feature0053,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0053,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1241971.0422098967,984228.5500213397,0.7924730259974951,-0.33556626489958646,0.3683692063001063,0.5073256846380017,Downregulated
Feature0052,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,590940.461982223,1089237.4614543878,1.8432270787495253,0.8822338166035244,0.06038328755520734,0.2524949108355725,Upregulated
Feature0051,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,152817.79662760042,7059386.43947397,46.194792722191195,5.529658328838717,0.0132972353176958,0.17552350619358453,Upregulated
Feature0050,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,47083.27539294307,68381.75323499943,1.4523576081805178,0.5383967260795325,0.04563621883260474,0.23169157253476252,Upregulated
Feature0049,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0049,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,303357.63060391,332043.58322242403,1.0945615001060214,0.13035301747482464,0.7938416701529099,0.8595908313223575,Upregulated
Feature0048,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0048,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1091425.0812140533,791124.2334960547,0.7248543643655713,-0.46423693274362327,0.7559250538647756,0.8309025702144934,Downregulated
Feature0047,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0047,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,1766132.9846941477,1319586.3657275126,0.7471613843144624,-0.42050820099831676,0.687673492870641,0.7785768506567702,Downregulated
Feature0046,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0046,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,104755.2853996725,164867.80620772066,1.5738375928116757,0.6542866741783622,0.20165514486435776,0.35539505387094084,Upregulated
Feature0045,NA,C15 H33 N O,243.2562,NA,NA,Feature0045,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1895845.2846623831,3001980.31144646,1.583452160222589,0.6630732808474935,0.5355818673979795,0.6589066394961985,Upregulated
Feature0044,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157690.94151944498,236407.25853959832,1.4991809691899567,0.5841745444560983,0.28533672996871395,0.4293916575771776,Upregulated
Feature0043,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0043,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,1696706.7993108449,654155.3441419094,0.3855441284302091,-1.375032097979527,0.4881974579574249,0.6196045321459395,Downregulated
Feature0042,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0042,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,572138.739297132,1163492.5721695544,2.0335846749319857,1.0240250633651606,0.06817798225814181,0.2566969667571648,Upregulated
Feature0041,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,686454.7896298197,1271597.7416204866,1.8524129495931019,0.8894057475831192,0.03952098121784562,0.2294308083870162,Upregulated
Feature0040,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0040,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Phenol,3090985.67660225,1963906.4653807867,0.6353657605879303,-0.6543407485579549,0.001379031097965392,0.1302431386388236,Downregulated
Feature0039,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,974563.809393726,1286053.7807763433,1.3196198836650772,0.4001224213065421,0.18798532354273256,0.34747863758640185,Upregulated
Feature0038,NA,C12 H17 N O4,239.11576,NA,NA,Feature0038,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Phenol,2961807.0381313134,499431.88881211367,0.16862404686809684,-2.568117806391692,0.006523510480289742,0.1493750767119406,Downregulated
Feature0037,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1245371.7548509466,1532301.9641847233,1.230397235376611,0.29912416677312637,0.05507492165629016,0.24513653722181605,Upregulated
Feature0036,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0036,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Phenol,2803268.7034831136,1897184.45193592,0.6767758116011615,-0.5632500883483164,0.131772571673199,0.30398802261806607,Downregulated
Feature0035,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0035,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,558095.4322272603,1336058.2243044267,2.3939601493824347,1.2593991369234983,0.1609881643481734,0.3180083105610045,Upregulated
Feature0034,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0034,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2849922.73269686,2738479.4202512833,0.9608960231914362,-0.05754776684543597,0.5081123208759242,0.6352400982281216,Downregulated
Feature0033,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,172907.85806138432,2932868.622422497,16.962032005400783,4.084237106092192,0.0644536092601394,0.2524949108355725,Upregulated
Feature0032,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0032,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Phenol,2206275.72222276,1795329.4706948767,0.8137375816682303,-0.2973644732018576,0.04785499824872968,0.23758100900475532,Downregulated
Feature0031,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0031,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,584890.5097751654,515731.02197462,0.8817565225547418,-0.18154775225105996,0.7561065277976807,0.8309025702144934,Downregulated
Feature0030,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,312781.44103396265,358578.41203799867,1.146418441109053,0.19713372186778785,0.8538388983653868,0.8970105280580187,Upregulated
Feature0029,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,115904.04591890286,220671.42281041766,1.9039147517319601,0.9289688830539987,0.10493768728079904,0.29231724387699126,Upregulated
Feature0028,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0028,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1463578.22879057,1508942.49979464,1.030995453547814,0.04403797076762715,0.8974843818589595,0.9298037640311659,Upregulated
Feature0027,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0027,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Phenol,273938.83809228963,126373.82280705866,0.46132130692794826,-1.1161561675620502,0.1677857757913572,0.3268327090935812,Downregulated
Feature0026,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,489701.6470529157,3761405.6873604134,7.681014981258511,2.9412969635084094,0.09537101781855198,0.29061626158377885,Upregulated
Feature0025,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0025,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,303513.38623245835,273109.211987435,0.8998259199621033,-0.15228216977725417,0.5866324594402096,0.7006338979169111,Downregulated
Feature0024,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0024,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,3111590.6350137265,3016723.76356015,0.9695117762645027,-0.0446696726200546,0.8050170001927037,0.8650288551238945,Downregulated
Feature0023,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0023,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,2438606.6057053367,1953157.844521677,0.8009319092108136,-0.3202484969717745,0.48872549995468484,0.6196045321459395,Downregulated
Feature0022,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0022,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,884673.9988960424,950660.0776158066,1.074588016379035,0.10378365456010773,0.670460427566175,0.766826299418194,Upregulated
Feature0021,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0021,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,130224.98436507443,141257.86904656832,1.084721720146759,0.1173249740450792,0.7274126467293611,0.8096795532047055,Upregulated
Feature0020,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0020,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1280482.7834953,744541.1355018397,0.5814534526340803,-0.7822643913089865,0.0143028149610822,0.18115825478491981,Downregulated
Feature0019,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Phenol,124744.71785889503,233046.70513899266,1.8681889633403428,0.9016403879631365,0.09655743700209991,0.29061626158377885,Upregulated
Feature0018,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,1451049.2337859767,617578.114639876,0.4256079671594148,-1.232402937295923,0.04938499893966529,0.23924543223939654,Downregulated
Feature0017,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0017,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,261321.688481575,248137.373139568,0.9495475656130372,-0.07468782389093417,0.8314879818562928,0.8776383025802076,Downregulated
Feature0016,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,1334663.543834382,1330671.8874854366,0.997009241492071,-0.004321217552768256,0.9936202699858507,0.9962841312994857,Downregulated
Feature0015,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0015,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,214825.16012306465,179480.846982051,0.8354740519184702,-0.2593330730040908,0.14968791531227157,0.3145128108246605,Downregulated
Feature0014,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0014,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,852045.722270269,1325066.54921306,1.555158971612968,0.6370620632080175,0.0394511550241984,0.2294308083870162,Upregulated
Feature0013,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2044680.3472333835,1996794.5688184567,0.9765803107171641,-0.03418940345412539,0.9587889171728253,0.9728255037004347,Downregulated
Feature0012,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Phenol,1333560.12614189,647924.2558016613,0.4858605495922893,-1.0413858001521925,0.02010880201997676,0.19619196405577324,Downregulated
Feature0011,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Phenol,80013.17316562496,103324.9006920691,1.291348619285346,0.36887853079097654,0.2639479562500784,0.4079465848703739,Upregulated
Feature0010,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0010,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,544594.5627195727,802557.141222122,1.473678211575134,0.5594215357990192,0.34199100489992396,0.48632941381205913,Upregulated
Feature0009,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0009,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,1025803.048159556,1221595.06005775,1.1908670599580242,0.25201236984010517,0.2558896600635064,0.40187006826893035,Upregulated
Feature0008,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,195882.65396950766,203476.27020349854,1.0387661494272635,0.05487090637469654,0.9374858820276251,0.9586479233215527,Upregulated
Feature0007,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0007,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,902934.8689776587,1229777.9980390433,1.3619786324471557,0.44570406964635817,0.11421786543569991,0.29530270911052897,Upregulated
Feature0006,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,281114.9137817087,426033.9989417113,1.5155154638025898,0.5998085729651913,0.0037652396558613063,0.1302431386388236,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,366566.055609247,636015.7522169653,1.7350645060680332,0.7949893001836522,0.024921982654126013,0.202913517900705,Upregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Phenol,1836263.9194603635,78804.71084514356,0.042915786783145254,-4.542347741952022,0.10693245436306524,0.2923176437002599,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,237269.5491988153,259388.99369875266,1.0932249611238685,0.12859030577004546,0.7990264559276341,0.8615149538706139,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Phenol,298225.9010841767,2025635.6401123991,6.792286091678694,2.7638972266108546,0.22881826665174873,0.3780008505232887,Upregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,80804.19015878683,73210.7331629739,0.9060264451522728,-0.14237493453501476,0.6014619172286955,0.7103581801374698,Downregulated
